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Abbreviation Definition
C Concordance index
CT Computed tomotography
EQ EuroQol
HRQoL Health-related quality of  life
LBP Low back pain
LSS Lumbar spine surgery
LSSS Lumbar spinal stenosis surgery
MCID Minimal clinical important difference
MDC Minimal detectable change
MID Minimal important difference
MRI Magnetic resonance imaging
OA Osteoarthritis
ODI Oswestry Disability Index
OLS Ordinary least squares
PIN Personal identity number
PRO Patient reported outcome
PREM Patient-reported experience measurements
PROM Patient-reported outcome measurement
RCT Randomized clinical trial
SD Standard deviation
SHAR Swedish Hip Arthroplasty Register
THR Total hip replacement
TTO Time trade off
VAS Visual analog scale
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Abstract
Patients and methods
For Paper I-III, data including PROMs on patients with 
THR and LSS performed in 2002–2012 were obtained 
from SHAR and Swespine and linked to identify those 
who occurred in both registers. In Paper IV, data from 
SHAR on patients with THR in 2002–2014 were used 
to establish the relationship between PROMs and 
reoperation. For Paper V, patients eligible for THR in 
western Sweden during 2015 were invited to answer 
EQ-5D-3L and EQ-5D-5L with a two-week separation 
before and after surgery. Logistic and linear regression 
analyses were used to investigate research questions.
Results
Patients with both THR and LSS performed had worse 
one-year PROMs following the last procedure compared 
to patients with surgery in only one location. Patients 
eligible for both THR and LSS within a short period of  
time had better outcomes following the last procedure 
if  surgery started with LSS. PROMs collected one 
year following THR predicted the risk of  subsequent 
reoperation. Patients frequently utilized the additional 
response options of  EQ-5D-5L and ceiling effects at 
the one-year follow-up were reduced compared to EQ-
5D-3L. EQ VAS estimates for different severity levels 
conformed well between questionnaires. 
Conclusion
This thesis contributes to the understanding of  patient-
reported outcomes for patients who undergo both THR 
and LSS. Given their ability to predict reoperations 
following THR, PROMs can be utilized to identify 
patients at increased risk, which may may be used to 
improve follow-up routines and care. Since EQ-5D-5L 
better describes health-related quality of  life in THR 
patients, the introduction of  the extended questionnaire 
as a standard tool in SHAR will enable a more accurate 
assessment of  the procedure.
Background
Beginning in the late 1990s, the Swedish Hip Arthroplasty 
Register (SHAR) and the Swespine have successfully 
implemented programs to collect patient-reported 
outcomes measures (PROMs). The use of  PROMs has 
enabled assessment of  patients’ health-related quality 
of  life (HRQoL), physical function and pain following 
total hip replacement (THR) and lumbar spine surgery 
(LSS). The nationwide collection of  PROMs has made it 
possible to evaluate changes of  care, compare providers, 
investigate factors influencing outcomes that matter 
for patients, and it has contributed to improvement in 
clinical practice.
Objective
The overall objective of  this thesis is to investigate 
different ways to utilize PROMs following total hip 
replacement and lumbar spine surgery. Specifically, this 
thesis aims to:
• Investigate PROMs in patients who have undergone 
LSS prior to THR and in patients who have 
undergone THR prior to LSS compared to matched 
patients with isolated THR or LSS.
• Investigate if  the order of  THR and LSS affects 
PROMs one year following the last procedure in 
patients with both procedures performed within a 
period of  two years. 
• Investigate if  PROMs can predict the risk for 
reoperation following THR. 
• Assess the measurement properties of  EQ-5D-
5L compared to EQ-5D-3L in a Swedish THR 
population and to estimate how different severity 
levels of  the two versions of  the questionnaire 
conforms.
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For many years to come the number of  primary total hip 
replacements and lumbar spine surgeries will continue 
to increase, not only in Sweden but also in a global 
perspective (1, 2). Several factors are able to explain 
this increase. Improved implant technology and surgical 
techniques make surgical procedures available for both 
older and younger patients. Due to improvements 
in general medical practice and educational level, the 
general health is improving resulting in increased life 
span, an increasing population and increased demand 
for these surgical procedures.
Both hip osteoarthritis and spinal stenosis are common 
degenerative diseases in the general population. 
Subsequently, the concurrence of  these musculoskeletal 
disorders is commonly encountered in clinical practice. 
Hip osteoarthritis and spinal stenosis often present 
with similar symptoms, which may make it difficult 
to determine the origin of  pain. The “hip-spine 
syndrome” was first described by Ofierski et al in the 
late 1970s. ref  (72–75) Due to the increasing life span 
of  the population, more and more people are likely to 
need total hip replacement (THR) and lumbar spine 
surgery (LSS) in one or both locations over time. In the 
presence of  concurrent symptomatic conditions in the 
hip and lumbar spine, the location with which to begin 
has long been the subject of  debate. Knowledge about 
the outcome in patients in whom both procedures are 
performed is limited.
For patients with hip osteoarthritis where non-surgical 
treatment is ineffective, total hip replacement is a well-
established and cost-effective treatment. The survival 
of  some prosthetics has been reported to be above 
95% at 10-years follow-ups. Since complications are 
uncommon after THR, few patients require reoperation 
following a standard THR procedure. Most providers 
of  joint replacement surgery have abandoned regular 
follow-ups after routine THRs. Unfortunately, an 
Introduction
important minority operated with THRs will experience 
complications, and some will need reoperation due to 
early or late complications. An event of  this kind might 
be devastating for the individual patient, often resulting 
in impaired function and disability (3–5). In addition, 
these events are very costly to society and the health 
care system. The opportunity to detect patients running 
a higher risk of  reoperation could possibly reduce 
the suffering and costs associated with patients with 
complications following THR.
Patient-reported outcome measures (PROMs) are 
essential tools in the assessment of  outcomes following 
THR procedures (6). One of  the most commonly used 
health-related quality of  life (HRQoL) instruments is 
the original three level form of  the EQ-5D, the EQ-5D-
3L (7, 8). However, the EQ-5D-3L has been questioned 
due to its low sensitivity and the lack of  descriptive 
richness, which has been shown following THR in 
several studies (9, 10). In response to this critisism of  
the EQ-5D-3L, a five level version of  the questionnaire 
has been developed, the EQ-5D-5L, which expands the 
range of  responses in each of  the five dimensions from 
three to five levels (11). However, the usefulness of  the 
5L version has not yet been established among Swedish 
THR patients.
Papers I-III presented and discussed in this thesis 
aim to use PROMs to explore the outcome following 
surgery in patients who undergo both THR and LSS 
and to investigate differences in patient-reported 
outcomes depending on the order in which surgeries 
were performed. Paper IV aims to investigate whether 
PROMs one year postoperatively are able to predict 
the patients who run a higher risk of  reoperation. The 
last paper (V) compares the new version of  the PROM 
instrument, the EQ-5D-5L, with the EQ-5D-3L in a 
Swedish total hip replacement population.
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Total hip replacement
Hip osteoarthritis (OA) is a common degenerative disease 
primarily affecting the aging population. In Sweden, the 
prevalence has been estimated at 10% in those over 85 
years but only at 1% in patients under 55 (12). Other 
reports indicate a significantly higher prevalence of  hip 
OA; 27% in individuals over 45 on plain radiographs (13). 
The natural course of  hip OA is progressive with the loss 
of  cartilage in both the caput femoris and acetabulum. 
As the chronic and irreversible degenerative progress 
continues, subchondral cysts and osteophytes may 
develop. Typical symptoms of  hip OA are pain on activity 
and stiffness of  the affected hip. However, pain generated 
from the hip may present in different ways, such as groin 
pain, radiating pain down the leg towards the knee, buttock 
pain, or pain radiating towards the back. The appearance 
of  pain can also differ. Some patients experience only 
pain on movement, while others have pain at rest, or even 
sleep-depriving pain. The majority of  patients also often 
suffer from reduced mobility, caused by pain and stiffness. 
Diagnostics
Since hip OA presents with different symptoms, 
diagnosing needs to be individualized to some extent. 
Symptoms of  hip OA may for instance be present with 
or without minimal radiographic findings. On the other 
hand, radiographic findings may be present without 
causing symptoms. Different sources of  information 
must therefore be considered for the assessment. They 
include the anamnestic information on symptoms, plain 
radiographs and/or other imaging technology. There 
are several other disorders, such as degenerative lumbar 
diseases or knee OA that can mimic hip OA symptoms, 
and this should be taken into account before making a 
diagnosis of  hip OA. 
Treatment
The first line of  treatment is non-surgical including 
physiotherapy, analgesics and information. If  non-
surgical treatment fails, the alternative is surgery. In 2016, 
17,000 THRs were performed in Sweden, and the vast 
majority were due to OA. This surgical treatment of  hip 
OA consists of  irreversible replacement of  the femoral 
head and the acetabulum with an artificial ball-and-socket 
joint. Sir John Charnley pioneered this procedure in the 
1960s. The excellent post-operative results and the cost 
effectiveness of  THR, this procedure has been regarded 
Background
as “the operation of  the century” (14, 15). Several studies 
and arthroplasty registers have reported the survival of  
some prostheses at above 95% at 10 years (16, 17). Even 
if  it is called “the operation of  the century”, it is not a risk-
free procedure. A systematic review concluded that the 
average 90-day mortality after THA was 0.7% (18). THR 
for hip OA is an elective procedure to relieve pain and 
improve mobility and HRQoL. As a result, expectations 
of  the outcome are reasonably high. Hip OA is not a 
life-threatening diagnosis, THR should therefore only be 
offered to those who will most likely benefit from the 
procedure. 
Reoperation of total hip replacement surgery
Although the majority of  THR patients will live the 
remainder of  their lives without requiring further surgery, 
some patients will need a reoperation due to early or late 
complications. These complications could be loosening, 
infection, fracture or dislocation of  the prosthesis 
(16). Every year in Sweden, about 2200 reoperations 
are performed on patients with THR (16). The SHAR 
defines a reoperation as any further surgery performed 
on the hip. A revision is a reoperation in which any 
implant components are exchanged, removed or added. 
Examples of  reoperations that are not revisions are 
open reduction, soft-tissue repair, debridement without 
exchanging implant parts, the removal of  heterotopic 
bone formation and the relief  of  hemorrhage. Generally, 
reoperations result in impaired function and disability and 
constitute a risk factor for repeat surgical interventions 
(3–5). The result following revision surgery are less likely 
to be as successful as the first operation (19). In addition, 
these events are very costly, in terms not only of  medical 
costs but also of  the costs of  loss of  productivity related 
to patients’ loss of  working capacity. It is therefore of  the 
utmost importance to minimize the risk of  these events.
The need for routine follow-ups and prediction of 
reoperation
As the incidence of  primary THRs is rising and 
complications are uncommon following THRs, few 
patients need a reoperation following a standard THR. 
The increasing numbers of  THRs produces an increasing 
number of  follow-ups, at an increasing cost. Those 
complications that do occur following THRs are often of  
an acute nature and cannot be foreseen on a return visit. The 
need for follow-ups after standard THRs for all patients 
has therefore been questioned (20, 21). As a result, many 
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health-care providers have abandoned routine follow-
ups after standard THRs. However, some complications, 
such as loosening of  the prosthesis, may be symptomatic 
and could possibly be detected at follow-up visits. Some 
complications require less extensive interventions if  they 
are detected at an early stage. Follow-up visits may also 
constitute an important function in identifying issues such 
as degenerative spinal conditions, contralateral hip disease, 
poor strength, limited hip range of  motion and impaired 
walking ability eligible for physiotherapy or further surgical 
interventions. Although routine follow-ups for all patients 
are not justifiable, it is desirable to develop measures to 
identify patients running a higher risk of  complications, so 
they can be called to follow-ups. Considering the extensive 
research on risk factors for reoperation following THR, it is 
feasible to establish methods to identify high-risk patients. 
These instruments could potentially include patient-
related factors (22–25), implant- and surgical procedure-
related factors (24, 25) and PROMs (26–28). Automated 
and individualized assessment of  variables associated with 
the risk of  reoperations could be used to detect patients 
that would potentially benefit from monitoring. However, 
no models that have a specificity high enough to be used 
in a clinical setting are as yet available.
Low back surgery
Lumbar spinal stenosis, spondylosis/spondylolisthesis 
and segment-related pain are degenerative low back 
diseases primarily affecting the aging population. LSS is 
the most common of  these diagnoses and its prevalence 
has been estimated at up to 60% among patients over 
the age of  60 on magnetic resonance imaging (MRI) 
(29). The prevalence of  these diagnoses is increasing in 
Sweden, just as it is in the rest of  the developed countries. 
The reason for this increasing trend is probably that 
these diagnoses are being more commonly diagnosed 
among the population. This is probably due to multiple 
reasons. In part, it could reasonably be explained by a 
change in the demographic situation, with an older age 
structure among the population, and that symptoms 
of  these diagnoses are not accepted as before, since 
the population imposes increasingly higher demands 
on physical activity at an older age. Another reason for 
the increasing trend for these diagnoses could perhaps 
be the increasing availability of  MRI. In some cases, 
lumbar spinal stenosis will require surgical intervention 
as a final treatment (30). In Sweden, the annual rate of  
surgery due to these diagnoses is close to 55–60 per 
100,000 inhabitants and in the past decade there has been 
a yearly increase of  5–10% according to the Swedish 
Spine Register, Swespine (2, 31). In the US, 14 per 10,000 
inhabitants over the age of  65 undergo lumbar spinal 
stenosis surgery (LSSS) each year, which represents a 
fourfold increase since 1985. LSSS has become the most 
common indication for spinal surgery in Sweden and in 
other European countries (31–34). 
Symptoms and diagnosis
The symptoms of  lumbar spinal stenosis are caused by 
a narrowing of  the spinal canal, compressing the neural 
structures as the nerve roots leaving the spinal cord. This 
narrowing is caused anteriorly by a bulging disc, dorsally 
by a thickening of  ligamentum flavum and laterally by 
osteophytes derived from osteoarthritic changes in the 
joint facets (35, 36). Another contributory factor to stenosis 
can be degenerative spondylolisthesis. This is caused by 
an ongoing degenerative process of  the lumbar spine 
segments that can lead to a forward slip of  the adjacent 
upper vertebra (37). The symptoms of  lumbar spinal 
stenosis and other degenerative disorders affecting the 
lumbar spine are characterized by back pain, numbness, or 
radiating pain to the buttocks and lower extremities, as well 
as muscle weakness. At a later stage, walking disability may 
also appear (38, 39). The symptoms are often referred to 
as pseudoclaudicatio or neurogenic claudication, and need 
to be distinguished from genuine claudicatio or claudicatio 
intermittens caused by arterial insufficiency. Lumbar spinal 
stenosis symptoms may mimic pain caused by hip and 
knee joint disorders or polyneuropathy. These differential 
diagnoses should be taken into consideration when 
determining the cause of  symptoms. As the conditions 
causing lower limb pain often coincide and contribute 
individually to the range of  symptoms a patient may 
experience, it is a diagnostic challenge to differentiate the 
origin of  the different pain components. While anamnestic 
information is of  the greatest importance in diagnosing 
these disorders, a diagnosis of  lumbar spinal stenosis 
requires image-technology confirmation. MRI is now the 
method of  choice and should be used, taking absolute 
and relative contraindications (for example a pacemaker, 
ear implant, or claustrophobia) into consideration. The 
grade of  lumbar spinal stenosis can be determined by 
using the Schizas 7-grade classification which is based 
on the morphology of  the dural sac as observed on MRI 
based on the rootlet/cerebrospinal fluid ratio (40). The 
grade of  lumbar spinal stenosis can also be measured 
with a cross section of  neural structures of  the spinal 
canal were 75mm2 or less has been shown to correlate with 
clinical symptoms, and is considered a confirmation of  
lumbar spinal stenosis (41). If  MRI is contraindicated a 
combined examination with CT (computed tomography) 
and myelography can be performed to make a correct 
diagnosis of  lumbar spinal stenosis. 
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Surgical and non-surgical treatment
The treatment of  degenerative diseases of  the lumbar 
spine such as spinal stenosis may consist of  physical 
activity and patient education, epidural joint injections, 
or surgical intervention. There is no strong evidence 
of  any long-term effects of  steroid epidural joint 
injections (42). Physiotherapy has been shown to 
postpone surgery by four to six months (43, 44), but 
there are no studies presenting physical treatment as 
a long-term solution. There is evidence that surgery 
is a better long-term alternative compared with non-
surgical treatment (45–48). The surgical treatments of  
these degenerative diagnoses of  the lumbar spine is 
decompression or decompression and fusion of  the 
affected segment. Decompression aims to ease pressure 
on the neural elements in the stenotic spinal canal. Since 
the description of  pedicle screws by Roy-Camille et al. 
in 1970 (49), the use of  the pedicle instrumentation 
of  affected segments to achieve fusion has gradually 
increased and it is now used routinely in spinal surgery. 
Fusion vs non-fusion
The significance of  instrumentation with pedicle screws 
in relation to the healing rate of  spinal fusion has been 
a subject of  debate. Two studies reported no differences 
in healing rates of  instrumented and non-instrumented 
fusions (50, 51). However, other research reported 
significant increases in fusion healing for instrumented 
fusions in clinical and animal studies (52–54). A 
Cochrane review from 2006 claimed strong evidence of  
higher fusion rates for instrumented fusion compared 
with non-instrumented fusion (55). It has been debated 
whether decompression causes instability of  the 
spine (56, 57). To prevent instability, it has therefore 
been customary to perform fusion as a complement 
to decompression, particularly in the presence of  
degenerative spondylolisthesis. However, according to a 
recent randomized clinical trial by Försth et al., fusion as 
a complement to decompression does not lead to better 
post-operative results or cost-effectiveness compared 
with decompression alone. These findings were true 
even in the presence of  degenerative spondylolisthesis 
preoperatively (58, 59). In a study of  biomechanics, 
Försth et al. found that the potential instability caused by 
decompression was minimal and removal laminectomy 
did not result in increased instability compared with 
bilateral laminectomy (60). They suggested that the main 
principle of  LSSS should consist of  decompression 
alone, even if  degenerative spondylolisthesis is present 
pre-operatively. 
Normal
Lumbar disc
Degenerative changes
Compressed nerves
Spinal canal
Spinal stenosis
Figure 1. Pictures presenting normal spinal canal and spinal stenosis.
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L4
B. Decompressive laminectomyA. Incision
C. Foraminotomy and facetomy D. Fixation
Figure 2. Pictures presenting decompressive and fusion surgery.
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Complications following LSSS
Surgical procedures for lumbar spinal stenosis are 
considered safe, with a reported mortality within 90 
days of  0.3–0.4% (61–63). However, there are other 
risks following LSSS. In a systematic review, the risk of  
surgical complications (nerve root injury, cauda equinae 
damage, bleeding in the spinal canal, dura lesion and 
wound infection) were reported in approximately 5–10% 
and general medical complications (anaesthesiological, 
cardiovascular, pulmonary, cerebral, kidney/urinary, and 
liver/GI) were reported in about 3% of  cases (64). A 
dura tear resulting in cerebral spinal fluid leakage has 
been reported at even higher levels of  2.1–16% (65–
69). Lumbar spinal stenosis surgery is not a lifesaving 
procedure, the goal is to maintain or increase activity 
levels, relieve pain and restore health-related quality of  
life (HRQoL). The decision to proceed with surgery 
should therefore only be made if  the patient has a 
substantial impairment and conservative treatment fails 
to control symptoms. 
Hip-spine syndrome
Up to 27% of  patients over 45 years have signs of  hip 
OA on plain radiographs (13) and 60% of  patients over 
60 have signs of  lumbar spinal stenosis on magnetic 
resonance imaging (MRI) (29). Due to the high 
prevalence of  these degenerative diseases of  the hip 
and lumbar spine, it is not surprising that the prevalence 
of  coexisting degenerative lumbar spine disorders has 
been estimated at up to 18% among a THR-population 
(70). Similarly, among patients eligible for lumbar back 
surgery, the prevalence of  osteoarthritis of  the hip or 
knee has been reported at 10% (71). The combination 
of  degenerative disorders of  the hip and lumbar spine 
is known as the “hip-spine syndrome” and was first 
described by Ofierski et al. in 1976 (72–75). These 
degenerative diseases may cause similar symptoms, which 
make determining the origin of  pain in clinical practice 
and assessing of  how these conditions contribute to 
symptoms problematic, as well as differentiating them 
from other diseases with similar symptoms, such as 
arterial insufficiency and polyneuropathy. 
Surgical outcome
In general, lumbar spine surgery and hip replacement 
are well-investigated interventions and the evidence 
of  their effectiveness in reducing pain and restoring 
mobility is comprehensive. However, there is some 
variation in outcomes and a great deal of  research has 
focused on exploring factors associated with better and 
worse results. Increased comorbidities affecting mobility 
and combinations of  degenerative musculoskeletal 
disorders have been shown to be associated with 
poorer outcomes following surgery. Comorbidities are 
defined as patient conditions or diseases not associated 
with the development or cause of  the immediate 
disease of  interest. Comorbidities can be diagnosed at 
different points in time, which may lead to different 
associations with the risk of  adverse outcomes (76, 
77). Since musculoskeletal comorbidity is associated 
with worse patient-reported outcomes following THR 
(78), patients with hip-spine syndrome are expected 
to have poorer outcomes after THR compared with 
patients with an isolated degenerative hip disorder. 
There are reports of  low back pain prior to THR being 
associated with poorer outcome and function following 
surgery (79, 80). Patients with a known degenerative 
disease in their lumbar spine have worse outcomes 
in terms of  function, physical-status, activity-levels 
and satisfaction after THR (81). Furthermore, THR 
patients who had been diagnosed with lumbar spine 
disorders experienced less improvement in function 
and pain compared with patients without a history 
of  lumbar spine disorder (5). Similarly, several studies 
report poorer outcomes following LSS in the presence 
of  preoperative conditions affecting walking capacity, 
such as hip osteoarthritis (71, 82–85). Reversely, LSS 
with the absence of  comorbidity and disorders affecting 
walking capacity prior to LSS are associated with better 
functional outcomes and pain relief  (85, 86). However, 
the knowledge of  the outcome following THR and LSS 
in patients with both procedures performed is limited.
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Where to perform surgery first: the hip or the spine?
For years, there has been an ongoing discussion about 
whether to perform surgery on the hip or spine for 
patients with hip-spine syndrome. Some argue that 
THR should be performed first because of  its reliable 
effectiveness (74). One argument in favor of  starting 
with THR is its association with reduced back pain 
and the fact that residual symptoms may be effectively 
treated with subsequent lumbar spine surgery (70, 73–74, 
87–90). Others favor LSS initially because of  the risk of  
contraction of  the spinal nerve roots during the THR 
procedure, which may cause nerve damage (91, 92). 
Previous research is therefore inconclusive and somewhat 
conflicting.
Pain caused by degenerative disease in the hip and 
lumbar spine
Pain is a complex and subjective experience that could 
be suspected to affect everyone at some time during 
a life span. When discussing pain from hip OA and 
spinal stenosis, both acute and chronic pain needs to be 
considered, as well as pain arising from nociceptive- and 
neuropathic pathways. 
Acute and chronic pain
Physiologically acute pain is meant to serve as an 
internal alarm system helping us to react to external 
dangers in our environment or to internal dangers 
caused by potentially harmful changes in our bodies. 
Chronic pain, on the other hand, is always maladaptive 
and the continuous somatosensory and emotional 
burden can seriously affect the sufferers quality of  life 
(93). Although chronic pain is a characteristic of  many 
different diseases, hip OA and low back pain as a part 
of  spinal stenosis are two of  the most predominant, 
putting them among the leading causes of  disability 
worldwide (93, 94). 
Nociceptive and neuropathic pain
Nociceptive pain is defined as pain arising from actual or 
threatening damage to non-neural tissue and it is due to 
the activation of  nociceptors (95), or as pain attributable 
to the activation of  the peripheral receptive terminals 
of  primary afferent neurons in response to noxious 
chemical, mechanical, or thermal stimuli (96). For clinical 
purposes, the term nociceptive pain can be used when 
pain is proportional to nociceptive input, and the term is 
designed to contrast with neuropathic pain. The latter is 
defined as pain caused by a primary lesion or disease of  
the somatosensory nervous system (95). Pain in hip OA 
is mostly caused by nociceptive pain, but up to 23% of  
patients also have neuropathic pain (97). Within the low 
back pain population lumbar radiculopathy is a common 
type of  lumbar neuropathic pain, while myofascial 
tissue (i.e. thoracolumbar fascia) (98) and some lumbar 
ligaments (99) contain nociceptors capable of  generating 
nociceptive pain. For patients with lumbar spinal stenosis, 
neuropathic pain have in general been reported to be 
present in more than one third, and for those patients 
with radicular pain neuropathic pain has been reported 
to be present in more than two thirds (100). Because of  
the high concentration of  nociceptors in somatic tissues, 
chronic somatic pain is typically well localized and often 
results from degenerative processes (such as arthritis). 
However, around 15–25% of  patients with chronic pain 
are thought to have neuropathic pain (101).
Pain referral pattern
Pain arising from both osteoarthritis of  the hip and 
lumbar spinal stenosis has complex pain referral 
patterns. Pain arising from both locations has been 
shown to be present in several locations other than just 
the hip or spine. There are several studies describing the 
pain referral patterns from both the lumbar spine (95, 
102) and hip OA (103, 104). The distribution patterns 
for the pain are similar in, for example, the buttocks, 
anterior and posterior thigh, groin, low back and knee. 
Hip OA has previously been thought not to radiate 
below the knee and that groin pain is associated with 
hip OA. However, these symptoms have been proved to 
originate from both locations (104). Due to the difficulty 
involved in determining the origin of  pain, diagnostic 
tests such as intraarticular injection of  the hip joint or 
spinal nerve root block with local anesthetics have been 
recommended (75, 91, 102, 105, 106).
Orthopedic registers
National prospective observational registers
National quality registers have three main objectives: to 
monitor outcomes, stimulate to improvement activities 
and to facilitate research. Since the SHAR registers type 
of  the prosthesis used in detail, implant surveillance 
is a fourth important objective. The national quality 
registers enables studies to determine the demography 
of  the population with certain conditions or undergoing 
a specific procedure. The opportunity to obtain large 
sample sizes provides high statistical power. Together 
with the continuous validation of  these registers, this 
provides for high reliability in the analyses of  survival 
and outcome of  implants and techniques. The large 
sample sizes and repeated validation processes in these 
registers enable certain confounders to be taken into 
consideration when determining whether differences 
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in outcomes are related to the implant or the technique 
in question. There are naturally data entry errors in all 
registers, but these have been proven to be minimal (16, 
107). Because of  prospective collection and continous 
validation procedures recall bias have been significantly 
reduced. When the registers are used for prospective 
observational register studies, the large sample 
sizes reduce selection bias and significantly reduce 
confounding bias and heterogeneity. 
Stepwise introduction of new implants
Registers monitoring implant survival such as the SHAR 
also play an important role in the introduction of  new 
prostheses and surgical techniques. It is preferable for 
the introduction of  new technologies or techniques to 
be performed step-wise, starting with a small cohort 
which is closely observed to determine eventual early 
complications. This step is followed by larger multicenter 
studies and that new technologies or techniques are finally 
investigated in large scale prospective observational 
register studies (108). A step-wise introduction of  this 
kind has the potential to eliminate failure at an early 
stage and prevents the premature introduction of  new 
prostheses, technologies and techniques on a nationwide 
basis. It is, however, important to consider the last step in 
the introduction of  observational register studies, which 
are by nature not designed to explain causation. Causation 
is determined through cohort and randomized controlled 
trials where causation can be determined. 
PROMs and registers
Since their development, observational orthopedic registers 
have been used to monitor the survival of  implants using 
revision as the endpoint. By doing this, the success of  a 
prosthesis has been based upon the survival of  the implant, 
the functional status performance assessed by the surgeon 
and plain radiographs. When measuring success in this way, 
interest focus not on the patient´s opinions of  the outcome 
but on the surgeon’s opinion of  the outcome following 
surgery. The opinion of  the patient is however most 
important, since the main indication for the procedure is 
pain and disability. However, in the last few decades this 
evaluation approach has shifted to measuring patient-
reported outcomes. Ultimately, patients are uninterested in 
their x-rays, or whether their walking ability as assessed by 
the surgeon is judged as good, if  they are still in pain and 
dissatisfied with the outcome of  surgery. Patient-reported 
outcome measures (PROMs) provide another dimension 
to success following orthopedic surgery. PROMs measure 
not just pain and function but also the patients HRQoL, 
which can be used to calculate the cost effectiveness 
of  procedures and techniques. PROMs also provide 
the opportunity to measure outcomes at both group 
and individual levels. Together with demographic and 
surgery-specific variables, PROMs enable further register 
developments aimed at optimizing the care of  patients in 
need of  orthopedic surgery. 
Linkage of register databases
Personal identity numbers (PIN) are used as a common 
identifier in most registers in Sweden, in both orthopedic 
registers, such as SHAR or Swespine, and in other 
national health data sources, such as Statistics Sweden or 
the Prescribed Drug Register. This enables the linking of  
registers, which in turn offer an important opportunity 
not only to study and adjust for a number of  confounders 
but also to add other outcome measures such as adverse 
events and sick leave. 
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The personal identity number
In 1947, the Swedish government introduced the 
personal identity number (PIN). The personal identity 
number is a unique 10-digit number. The first six digits 
contain the birth date (year, month and day). A hyphen 
separates them from the serial number made up of  the 
three digits, where the third digit identifies the sex, odd 
numbers for males and an even number for females. 
The tenth and last digit is a control number. All citizens 
in Sweden have their own unique PIN. Since this has 
been used in the majority of  health registers, research 
by register data has been very successful in Sweden. 
Using a personal identity number makes it possible to 
link data from different registers at individual level. By 
doing this, registers complement one another with data 
by reducing confounding and enabling more complex 
research questions. 
Swedish Hip Arthroplasty Register
The Swedish Hip Arthroplasty Register (SHAR) began in 
1979. Its purpose was to gather prospective observational 
data on all hip replacement surgery in Sweden at both 
publicly and privately funded hospitals. The data that are 
collected are used to compare results across providers and 
to monitor longitudinally outcomes of  the procedures 
with the emphasis on implant types, surgical techniques, 
and complications. As the SHAR collects PROMs data 
continuously on the Swedish THR population both 
before and at one, six, and ten years after surgery, the 
register is able to attain a higher statistical power than a 
randomized controlled trial or data collected at a single 
hospital. Due to the large size and complete coverage, 
the register is also able to quickly identify complications 
associated with both implants and surgical techniques. 
Since 1992, all orthopedic clinics, both public and private, 
have reported their primary surgeries and subsequent 
reoperations to the SHAR. In the SHAR coverage is 
100%, and the completeness of  THR registrations has 
been reported as 98.1 % (16, 107). 
PROMs in SHAR
In 2002, the SHAR launched a nationwide PROMs 
program for elective THR patients. The program 
reached full participation among Swedish orthopedic 
hospitals in 2008. The purpose of  the program was 
to complement the traditional outcome variables, such 
as implant survival, with patient-reported outcomes 
relating to pain, function and health-related quality of  
life (6, 77). The PROMs program invites all patients 
scheduled for elective THR to participate. Patients are 
asked to complete a short questionnaire at their pre-
operative visit. A follow-up survey to be answered 
manually is mailed to patients at one, six, and ten years 
post-operatively. Every month, the SHAR centrally 
distributes lists of  patients that are to receive follow-
up questionnaires to the orthopedic departments 
where specially trained secretaries at the departments 
are responsible for sending out questionnaires and 
reminders and entering data in the on-line PROM 
database. Response frequencies have been reported as 
86% pre-operatively, and 90% at the one-year follow-up 
(6). The PROMs program comprises the EQ-5D health 
status questionnaire (109), a hip pain visual analog scale 
(VAS) (110) and at follow-up a VAS addressing outcome 
satisfaction. Additionally, the patient’s musculoskeletal 
comorbidity is determined using the Charnley 
classification (111). The PROMs program in the SHAR 
is the voice of  all patients operated with a THR. This 
information provides an excellent opportunity for 
developing improved healthcare and providing better 
outcomes for patients operated with a THR.
Swespine
The Swedish Spine Register (Swespine) was started in 
1993. Its aim was to prospectively gather observational 
data on all surgical procedures on the spine performed in 
Sweden from both publicly and privately funded hospitals. 
As in the SHAR, the collected data are used to compare 
results across providers and to monitor longitudinally 
the outcomes of  the procedure, focusing on surgical 
techniques and complications. The surgeon’s contribution 
to the register is to make the diagnosis and classification, 
together with details of  the surgical technique, implants 
and perioperative complications. The completeness of  
registrations to the Swespine has been reported as 85% 
(2). The unique personal identity numbers (PIN) given to 
all inhabitants in Sweden are used as identifiers.
PROMs in the Swespine
The PROMs included in the Swespine comprises 
questionnaires containing the EQ-5D-3L (112), the 
Oswestry Disability Index (ODI) (113), back and leg 
pain according to a visual analog scale (VAS) (110), and 
until recently the Short Form 36 (abbreviated health 
survey, SF-36) (114). Questionnaires are filled out at the 
pre-operative visit, or sent to patients prior to surgery. 
The same questionnaire, together with a questionnaire 
regarding satisfaction with the treatment, is filled out 
at follow-ups one, two, five, and ten years following 
surgery. The questionnaires are unrelated to any hospital 
visit, and are completed without the assistance of  the 
surgeon or any other person involved in the treatment. 
The Swespine distributes lists of  patients due to receive 
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follow-up questionnaires to the orthopedic departments 
and specially trained secretaries at the departments are 
responsible for sending out questionnaires and reminders 
and entering data in the online Swespine database.
Importance of register data quality
The quality of  a register analysis or prospective register 
studies using register data depends largely on the quality 
of  the data in the current registers database. There 
are five dimensions in particular that need to be take 
into consideration; validity and reliability, coverage and 
completeness and response rates. Both the SHAR and 
Swespine are continuously working on data validation. 
The SHAR does this by examining medical records from 
all reoperations. Once a year, all orthopedic departments 
are also requested to compare the register´s numbers with 
each local hospitals’ patient administration system. The 
register online entry application also has a built-in warning 
system for incorrect entries such as the wrong PIN, paired 
side and implants. When it comes to the reliability of  a 
register it is important that the variables that are included 
have high consistency or precision of  the measuring 
instrument. The coverage of  a register is simply calculated 
as the proportion of  participating units compared with 
all units, where a high number is good. There are pitfalls 
to take into consideration, if  the coverage is calculated 
as a possible coverage and not an actual coverage. The 
coverage is misleading and not a “true coverage”, that 
should be on an individual procedure level. Completeness 
depends on that the respective participating unit’s report at 
individual level. Both the SHAR and Swespine collaborate 
with the Swedish National Board of  Health and Welfare 
which operates the National Patient Register based on 
PINs. Departments are required by law to report all 
medical interventions to the Patient Register. Each year 
a linkage between the Swedish Hip Arthroplasty Register 
and the Swespine respectively with the National Patient 
Register is performed. In this way registers completeness 
can be calculated at both departmental and individual level. 
The figures are published each year in respective registers 
Annual Reports and this has led to some out-liers rapidly 
improving their registration. Poor completeness may lead 
to flawed analyses and feedback will then be misleading, 
so, if  some departments have low completeness they have 
usually improved their registration.
Prospective observational studies
Prospective observational studies such as register 
studies obtain data from groups who have or have not 
been exposed to the subject of  interest. In these studies 
there are no interventions exposure by the researcher or 
anyone else. Prospective register studies are preferable 
when investigating the effects of  predictive risk factors 
on an outcome. To study the effects of  an intervention, 
randomized clinical trials (RCT) are the gold standard. In 
an RCT, the participants are assigned to either intervention 
or control/placebo, preferably using a blinded random 
selection. There are advantages and disadvantages to both 
types of  study. In an RCT the advantages are the unbiased 
distribution of  confounders, the opportunity to blind 
the researcher, and the fact that randomization enables 
statistical analyses. The advantages of  observational 
studies are that they are ethically safe, less expensive, 
and require less administration than an RCT. RCTs often 
includes too few observations to investigate rare events. 
The larger amount of  data is a strength of  register studies 
together with the opportunity to match study groups. 
Register studies also investigate the performance or effect 
of  an intervention in everyday practice, and not only 
in a specific clinical or laboratory environment. They 
therefore prevent performance biases and the results 
can often be generalized. The disadvantages of  register 
studies are that there are no controls and that there may 
be hidden confounders. In observational studies such 
as register studies, there is also always the risk of  bias: 
selection bias, detection bias, reporting bias and so on 
(115). There can also be problems achieving completeness 
and response rates that are needed for sufficient analyses. 
It has previously been stated that randomization is not 
possible in register studies, but there are now studies in 
which randomization occurs at registration and cluster 
randomization studies that also use registers. A well-
performed example of  a register RCT is the TASTE-study 
by the Swedish Coronary Angiography and Angioplasty 
Registry (116). 
PROMs
PROs
A patient-reported outcome (PRO) is a patient’s direct 
self-reported health status at any time, without external 
interpretation. However, outcomes do not necessarily 
have to be reported directly after an intervention: PROs 
can be presented at any time and represent the individual’s 
valued feelings, functional ability, pain, and so on with 
respect to their health status at that particular moment. 
PROMs
A patient-reported outcome measure (PROM) is a 
standardized instrument to measure PROs such as 
HRQoL, pain, functional impairment, or activity level. A 
PROM can be either generic or specific. A generic PROM 
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measures PROs not specific to treatment or disease and 
can be used to compare results across different populations 
and study groups, such as between different registers. The 
EQ-5D is an example of  a generic PROM (7, 8). Specific 
PROMs measure constructs of  health specific to a defined 
treatments or interventions, a disease or conditions, 
or specific body regions. These are important when 
investigating a specific outcome for a particular disease 
or following a treatment, but they cannot be used across 
areas other than those investigated. The Oxford Hip Score 
(117) is an example of  a specific PROM. 
Important factors of PROMs design
To analyze outcomes, PROMs must be valid and reliable. 
Other requirements for the instrument are a design 
providing for the highest possible response rate but at the 
same time sensitive enough to detect even small changes 
following a treatment or intervention. There is always 
the risk of  floor or ceiling effects if  patients choose to 
answer in the extreme when using scales such as a VAS 
or EQ-5D. It is therefore important that the instrument 
has enough levels to prevent these effects. Implementing 
PROMs to investigate any changes following a treatment 
or intervention is a delicate task. If  the applied instrument 
is unable to detect changes, no reliable analyses are 
possible. However, if  there are too many questions, the 
response rate will also be too low for a reliable analysis.
Interpreting PROMs
There are also several considerations when interpreting 
PROMs, besides the risk of  floor or ceiling effects. Scores 
from the same instrument may vary between populations. 
For instance, there are several national value sets for 
the EQ-5D index, which is a weighted measure. These 
value sets are specific to the nation’s cultural norms and 
are based on studies of  the general population using 
time trade-off  or VAS studies. Populations may value 
measured areas differently because of  cultural differences. 
To account for these differences, national value sets 
weight the patient’s responses differently. As a result, 
comparisons of  PROMs such as the EQ-5D between 
nations are difficult, and imply that trends, rather than 
exact values, need to be taken into account. It may also be 
difficult to decide whether changes measured following 
a treatment or an intervention actually are big enough to 
represent a clinically relevant difference. 
Minimal important difference
As PROMs have become a tool that is frequently used 
by both clinicians and decision makers in the assessment 
and comparison of  treatments and interventions, there is 
a need to determine the level of  change that constitutes 
a minimal important difference (MID). Several methods 
with similar denominations (e.g. minimal clinical 
important difference, MCID and minimal detectable 
change, MDC) confirm clinical relevance and its 
usefulness for implementation in clinical practice (118). 
However, since these MID tools are specific to different 
PROMs, conditions, interventions and populations, 
there are no standard MIDs. MIDs therefore needs to 
be interpreted with caution and should take account 
of  measurement error for the PROM. One example 
of  this is the MDC90, which is an MDC estimate with 
a confidence level of  90% (119, 120). Further, MIDs 
calculated from individual responses may not be able to 
be translated into changes measured at population level. 
One example is, if  an MID value is established at patient 
level and the average change for a population is below 
that MID value, the distribution of  change is then more 
important than the average change. A distribution with a 
narrow change probably indicates ineffective treatment. 
However, a broad distribution of  change indicates that 
treatment was probably either beneficial or harmful to 
some portion of  the population (121). MID values can 
be difficult to interpret and misunderstandings of  their 
implications for a population level compared with a 
patient level occur frequently. Small changes at population 
level are easily dismissed as clinically irrelevant when they 
may actually show significant differences following the 
treatment of  a group within the larger population (122).
PREMs
Patient-reported experience measurements (PREMs) 
are not to be confused with PROMs. PREMs represent 
the patient experience of  their care, not the outcome 
following an intervention. PREMs can provide a patient 
perspective on care and thus be useful for improvements 
at a single clinic (123), but their usefulness for national 
quality registers can be questioned. PREMs have not 
been used in any of  the studies in this thesis.
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The EQ-5D
One of  the most commonly used health-related quality 
of  life (HRQoL) instruments is the original three-
level form of  the EQ-5D, the EQ-5D-3L (7, 8). This 
is a short survey and it is recognized as valid in many 
populations and conditions, including THR populations 
(8, 112). The EQ-5D descriptive system includes five 
dimensions of  health: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. Each dimen-
sion is covered by one question with three levels of  
severity: no problems, moderate and severe problems. 
The descriptive system yields 243 possible health states. 
By applying weights from a specific value set, each 
health state can be transformed into a single index, 
which serves as an overall measure of  HRQoL. There 
are different index value sets for different countries to 
reflect response norms for a given population.
Strengths and weaknesses of the EQ-5D
The EQ-5D questionnaire is short, making it easy to 
complete, thus contributing to high response rates. 
The nature of  the EQ-5D makes it useful not only 
for comparing HRQoL between populations but also 
for calculating cost effectiveness between treatments 
or interventions. There are, however, limitations to 
the EQ-5D. The national value sets are specific to 
a nation’s cultural norms based on studies of  the 
general population using time trade-off  or VAS studies. 
Populations may value measured areas differently 
because of  cultural differences. To account for these 
differences, national value sets weight patient responses 
differently. As a result, comparisons of  PROMs such 
as the EQ-5D between nations are difficult and this 
implies that trends rather than exact values should be 
taken into consideration. Moreover, when measuring 
a change over time or after an intervention, floor or 
ceiling effects may appear. If  an individual has a high 
EQ-5D index prior to an intervention, there is little 
room for improvement, resulting in a ceiling effect. 
However, an individual with a low EQ-5D would have 
a much higher capacity for improvement. This creates 
strong dependence on the patient’s status prior to an 
intervention to measure change the intervention brings 
about in the patient’s HRQoL. Clustering has also been 
observed in the indices. For example, in the Swedish 
OA-population eligible for THR using the British value 
set, indices of  0.088 and 0.69 are very common (6). 
There was no Swedish value set until 2014 when 
Burström et al. developed a Swedish value set using the 
time-trade off  method (TTO) (124). For this reason, 
the register used the British value set. The index ranges 
from a minimum value of  -0.594 to a maximum value 
of  1.0. Negative values through 0 represent the worst 
possible health state and 1 represents the best possible 
health state. Following a study in 2015 by Nemes et al. in 
which they stated that the Swedish value set was better 
suited to a Swedish THR population than the Brittish 
value set (125), the SHAR changed to the Swedish value 
set in 2016.
The survey also comprises a vertical visual analog 
scale (EQ VAS), where the patient describes their total 
health from 0 (worst) to 100 (best). The briefness and 
simplicity of  the survey makes it a popular instrument 
for assessment (7). The EQ-5D-3L is a part of  the 
standard follow-up procedures for patients both pre- 
and postoperative in several arthroplasty registries (6, 8, 
9, 11, 126, 127). In 2002, the SHAR started to register 
PROMs using the EQ-5D-3L survey (16, 107). 
EQ-5D 5L
The original version of  the EQ-5D, the EQ-5D-3L, has 
been questioned, due to profound ceiling effects, low 
sensitivity and the lack of  descriptive richness. As it has 
a limited ability to measure small yet clinically relevant 
changes in the outcome following interventions, its 
usefulness in assessing interventions has been debated 
(128–130). These limitations have been reported for both 
the general population and specific patient groups (128–
132), including THR-populations (9, 10). Among THR 
patients, the EQ-5D-3L exhibits particularly difficulty in 
assessing outcome in the mobility dimension, where the 
options “no problems”, “some problems” and “confined 
to bed” limits its use in describing the limitations in 
mobility commonly experienced by patients with hip 
disorders. These patients typically experience limping, 
a limited range of  hip joint motion, impaired walking 
capacity and often require different aids for mobility, but 
they are seldom confined to bed. Similarly, the response 
levels of  self-care and usual activities (“no problems”, 
“some problems” and “unable”) limit the range of  
responses for individuals with moderate to severe 
disability (10, 133, 134).
So, the EuroQol group has developed a new version of  
the questionnaire, the EQ-5D-5L, offering respondents 
five levels of  responses instead of  three: no, some, 
moderate, severe and extreme problems (11). In the 
three-level survey, a response of  “no problems” in all 
dimensions would be notated as 11111 and “severe 
problems” as 33333. For the five-level survey, “no 
problems” in all dimensions would also be notated as 
11111, but a response of  “extreme problems” in all 
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five dimensions would be notated as 55555 to reduce 
the floor and ceiling effects. This gives the new five-
level version 3,125 unique health states instead of  243 
in the three-level version. The idea is that the increased 
number of  response levels will provide a better profile 
of  the patient’s health. The EQ-5D-5L instrument has 
been compared with the 3L version in several studies and 
been reported to be valid, to reduce ceiling effects and 
to increase discriminatory power in several populations 
(132, 135–137), as well in THR populations (9, 10). For 
those populations (for example Sweden’s) where no 
five-level value sets are available to calculate an index 
score, “crosswalk”-algorithms are available from 3L to 
5L (11). The 5L version is yet to be tested and validated 
in a Swedish THR-population.
EQ-VAS
The second part of  the EQ-5D contains a VAS 
addressing general health (EQ VAS) (112), where 0 
and 100 represent the worst and best possible health 
state, respectively. The floor or ceiling effects and the 
multimodal distribution of  indices have made the EQ-
5D subject to criticism (138–144). These facts need to 
be taken into consideration when performing statistical 
analyses of  the EQ-5D. Despite this, the EQ-5D is a 
useful tool for measuring patient HRQoL pre- and post 
THR surgery. 
Pain VAS
The pain VAS (110) ranges from 0 to 100, where 0 
represents no pain and 100 the worst possible pain. 
In the SHAR, the hip pain VAS is registered pre- and 
postoperatively at one, six and ten years (16, 107). In the 
Swespine the leg and back pain VAS is registered pre- 
and postoperatively at one, two, five, and ten years (2).
Oswestry Disability Index
The Oswestry Disabilty Index (ODI) is frequently 
used to measure the degree of  disability and estimate 
quality of  life in a patient with low back pain. The self-
completed questionnaire contains ten topics concerning 
intensity of  pain, lifting, ability to care for oneself, ability 
to walk, ability to sit, sexual function, ability to stand, 
social life, sleep quality, and the ability to travel. Each 
topic’s category is followed by six statements describing 
potential scenarios in the patient’s life relating to the 
topic. Each question is scored on a 0–5 scale with zero 
indicating the least disability and five indicating the most 
severe. The scores for all questions are then summarized 
and multiplied by two to obtain the index, ranging from 
0 to 100. Zero is equated with no disability and 100 is 
the maximum possible disability (113). In the Swespine 
the ODIs are registered pre- and postoperatively at one, 
two, five, and ten years (2). 
Other measurements used  
in these studies
Satisfaction
In the SHAR satisfaction with the outcome following 
THR was measured by the satisfaction VAS. This scale 
ranges from 0 to 100, where 0 represents very satisfied 
and 100 very dissatisfied. In the SHAR, satisfaction VAS 
is registered postoperatively at one, six and ten years (16, 
107). In the Swespine outcome satisfaction following 
LSS is measured by the patient rating the experienced 
outcome using a three-level questionnaire: 1. Satisfied, 
2. Uncertain, 3. Dissatisfied. Satisfaction is registered at 
one, two, six and ten years following surgery (2). 
Charnley class
The Charnley classification is a patient-reported survey 
in the SHAR, but was originally developed to be 
assessed by an observer, such as the orthopedic surgeon. 
The classification determines the musculoskeletal 
comorbidity status of  the patient according to: Class 
A, corresponding to a unilateral hip disorder, Class B, a 
bilateral hip disorder, and Class C, a walking impairment 
due to multiple joint involvement or other medical 
comorbidities (111). The question of  whether to divide 
Class B into two groups, those with one side or the other 
already treated, has been discussed (145). However, the 
evidence for this is not yet strong enough for a new 
fourth class. In the SHAR, the Charnley classification is 
registered preoperatively (16, 107). 
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The overall objective of  the studies presented in this thesis was to investigate the clinical utility of  
PROMs following THR and LSS. Specifically, the aims were to:
• Explore patient-reported outcomes following THR and LSS in patients in whom both 
procedures have been performed and to compare these results to patients in whom only 
one of  the procedures was performed. (Paper I and II)
• Explore whether the order of  THR and LSS procedures in patients in whom both 
procedures have been performed within a short period of  time of  two years influences 
the patient-reported outcome following the last procedure. (Paper III)
• Investigate the opportunity to use PROMs one year following THR in order to predict 
the risk of  a late reoperation following THR. (Paper IV)
• Calculate for the 3L and 5L-verions of  the EQ-5D an estimate for the different response 
options by dimension using the EQ VAS. To assess the measurement properties of  the 
EQ-5D-5L and investigate any differences compared with the EQ-5D-3L, preoperatively 
and one year postoperatively in a Swedish THR-population. (Paper V)
Aims 
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Patients and methods 
Patients
The data used for papers I, II and III were retrieved 
from the SHAR and the Swespine for patients 
undergoing surgery from 2002–2012. These years were 
selected since the SHAR first started to collect PROMs 
in 2002. After linking of  the registers using the PIN as 
a common identifier, selections were made based on 
predefined selection criteria specific to the respective 
studies. For each study, a separate dataset was compiled. 
In paper IV, demographic, surgical and PROMs data 
were retrieved from the SHAR covering patients 
undergoing primary THR in 2002–2015. In order to 
reduce confounding, patients included in the analysis 
were selected according to preset criteria. In paper V, all 
patients were recruited from one of  the seven publicly 
funded hospitals in western Sweden in 2015. A separate 
database was established for the EQ-5D-5L versions of  
the surveys while the EQ-5D-3L versions of  the survey 
were retrieved from the regular PROMs database. All 
the data sets that were used have been stored within the 
highly protected IT infrastructure of  the SHAR at the 
Register Centre of  Västra Götaland Region. 
Table 1 summarizes the number of  patients included in 
the different studies. A clarification is needed to explain 
the differences regarding patients and procedures 
between Papers I and II-III. Due to a misunderstanding 
between authors and statisticians in Paper I the SHAR 
dataset was expanded until 2013 and the Swespine dataset 
from 1998 to 2014. However, only patients with LSS 
prior to THR were included. As a result, only 86 patients 
with surgery outside the selected years, 2002–2013 were 
included in the study population in Paper I. This mistake 
was discovered after publication. These extra patients did 
not affect the outcome or analysis of  the studies. This has 
been carefully investigated and results without these 86 
patients are presented in Table 5. 
Table 1
Tot. no of procedures Tot. no of patients Year of surgery Comments
Paper I 
SHAR
Swespine
Study group
Matched group
139,697
47,433
 109,306
 43,767
997
997
2002–2013
1998–2014
Study and control group following 
selection Fig 3
Paper II
SHAR
Swespine
Study group
Control group
159,247
34,559
126,752
 25,394
220
220
2002–2012
2002–2012
Study and control group following 
selection Fig 5
Paper III
SHAR
Swespine
Study group
159,247
34,559
126,752
 25,394
255
2002–2012
2002–2012
Study group following selection Fig 6
Paper IV
SHAR
Study population 
-number reoperated
141,300
 75,899
  1,405
2002–2014
All THRs in Sweden 2002–2014, 
study population selection Fig 7
Paper V
THRs
Preop 3L
Preop 5L
Postop 3L
Postop 5L 
   1,567
   1,182
 767
1400
 508
2015
2015
2015
2016
2016
All patients eligible for THR in 
western Sweden in 2015 were 
intentionally invited to take part in 
the study
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Ethical considerations
According to the Patient Data Act (SFS2008:355), the 
collection of  data in Swedish national quality registers 
does not require written or oral consent from patients. 
The law obliges the health-care provider to inform 
patients that data will be registered and used for quality 
improvement and research and that they may opt out at 
any time and have their data deleted from the register. 
Written information about the collection of  data for 
quality registers is normally provided before or at the 
preoperative visit. Ethical review board approval is 
required for all research using national quality register 
data. Information on ongoing research projects is 
provided by the respective registers and is ideally posted 
on the register webpages.
For Paper V, patients were recruited from all public 
hospitals performing THRs in the Västra Götaland 
Region in 2015. Information about the study was 
provided before or at the pre-operative visit by each 
participating unit. Repeat study information was 
included when follow-up questionnaires were sent out. 
The return of  questionnaires was regarded as consent 
to participate. Information about the study was also 
available at the SHAR website. 
For all studies presented in this thesis, ethical review 
board approval was obtained from the Regional Ethical 
Review Board in Gothenburg, Sweden (Papers I-III 
entry number 236-13, Paper IV entry number 368-17, 
and Paper V, entry number 516-14).
Methods
Papers I and II
Papers I and II generally had a similar study structure. 
Following linkage of  the SHAR and the Swespine a set 
of  predefined step-wise selection criteria was applied 
in both studies (Figures 3 and 5). Following these 
steps a study population containing a study group and 
control group was created. In Paper I the influence 
of  a previous LSS on PROMs one year following 
THR compared with a group with only THR was 
investigated. In Paper II the opposite, PROMs one 
year following LSSS in patients with and without a 
THR prior to LSSS, was investigated. 
In Paper I there was an additional investigation were the 
prevalence of  a prior LSS among patients with THR due 
to hip OA during 2012 was calculated (Figure 4).
Both studies are prospective observational register 
studies presenting the outcome without drawing 
conclusions on causality. 
Paper III
Paper III is similar to Papers I and II in terms of  study 
structure. As in the previous papers, the SHAR and 
Swespine were linked and a set of  predefined selection 
criteria was then applied in a step-wise fashion (Figure 
6). The study group consisted of  patients who had 
undergone both THR and LSSS within a two-year 
period. We investigated whether the order of  surgery 
influenced PROMs (EQ-5D and EQ VAS) one year 
after the last procedure. 
As for Papers I and II, this study is a prospective 
observational register study presenting the outcome 
without drawing any conclusions on causality. 
Paper IV
For Paper IV data from SHAR were obtained and a set 
of  predefined step-wise selection criteria was applied 
(Figure 7). From the selected study group a study 
population of  those patients with a late reoperation 
was identified. The outcome was reoperation for 
all reasons and all types of  surgical procedures later 
than one year after the index surgical procedure. An 
investigation was then made of  the opportunity to 
predict the risk of  late reoperation. The predictors 
of  reoperation were age, sex and PROMs collected 
from the PROMs program in the SHAR (146), which 
includes the EQ-5D health status questionnaire (109), 
a hip pain visual analogue scale (VAS) (110) and, at 
follow-ups, satisfaction with the outcome using a VAS. 
A patient-reported Charnley classification used to 
determine patient-reported musculoskeletal comor-
bidity was also included (111). 
Paper V
In order to study the aim and research questions in 
Paper V, the aim was to invite all patients eligible for 
THR in 2015 on the basis of  primary hip osteoarthrosis 
at any of  the seven publicly funded hospitals performing 
THRs in the western region of  Sweden (Västra 
Götalandsregionen). During the standard preparatory 
preoperative visit prior to the THR procedure patients 
regularly completes the EQ-5D-3L questionnaire as part 
of  the routine PROMs program of  the SHAR (147). 
Two weeks prior to this visit, invitation letters including 
preoperative information are sent to the patients by 
each hospital’s waiting list coordinators. During the 
study period, these letters also included the 5L version 
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Figure 3. Selection of  patients undergoing THR with or without previous LSS. 
LSS = Lumbar spine surgery,  
THR = Total hip replacement,  
SHAR = Swedish Hip Arthroplasty Register,  
Swespine = Swedish Spine Register
of  the EQ-5D questionnaire and a pre-addressed return 
envelope to the SHAR. After the 5L version of  the 
questionnaire had been completed, it was sent directly 
to the SHAR and registered in a separate EQ-5D-5L 
database. No reminders were sent to patients regarding 
the preoperative 5L versions (Figure 8). One year 
following the index-procedure, the postoperative 3L 
surveys are sent to all patients by the SHAR-affiliated 
secretary at each hospital. The postoperative 3L versions 
were returned to the hospitals and registered into the 
SHAR PROMs database. This is general practice 
within the SHAR PROMs program. Non-responders 
were reminded after one month. Two weeks following 
registration of  the 3L version, the 5L version was sent 
out together with information about the study and a 
pre-addressed envelope to the SHAR. After the survey 
was returned to the SHAR, the answers were entered 
into the 5L database at the SHAR (Figure 8). 
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Figure 5. Selection of  LSSS patients with and 
without previous THR.
LSSS = Lumbar spinal stenosis surgery,  
THR = Total hip replacement,  
SHAR = Swedish Hip Arthroplasty Register,  
Swespine = Swedish Spine Register
Figure 4. Flow diagram showing the prevalence of  previous LSS 
in patients undergoing THR in 2012. 
LSS = Lumbar spine surgery,  
THR = Total hip replacement,  
SHAR = Swedish Hip Arthroplasty Register,  
Swespine = Swedish Spine Register
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Figure 6. Selection of  patients with THR and LSSS performed within two years.
LSS = Lumbar spine surgery,  
LSSS = Lumbar spinal stenosis surgery,  
THR = Total hip replacement,  
SHAR = Swedish Hip Arthroplasty Register,  
Swespine = Swedish Spine Register
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Figure 7. Flowchart describing the selection process
SHAR = Swedish Hip Arthroplasty Register,  
THR = Total hip replacement,  
PROM = Patient-reported outcome measures
Figure 8. Preoperative and one-year postoperative procedures for collecting the EQ-5D-3L and -5L questionnaires. 
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Statistical methods
Descriptive statistics
Throughout the thesis data on categorical variables are 
presented using frequencies and proportions. Moreover, 
data on continuous variables are presented using means 
and standard deviations (SD). 
Comparing means or proportions
Raw data were summarized as frequencies for 
categorical data and means and associated standard 
deviations for continuous data. The group comparisons 
were conducted using the Chi-square test for categorical 
variables and a t-test for continuous variables. 
P value below 0.05 represent significant differences.
Matching procedures
In Papers I and II, the one-to-one matching was 
performed with a non-parametric matching method, 
nearest-neighbor matching (148).
Regression models
Papers I and II
Post-operative PROMs data were modeled with linear 
regression analysis with the post-operative value as the 
outcome and LSS as exposure in Paper I, and THR 
as exposure in Paper II. In Paper II, satisfaction was 
modelled with logistic regression analysis. To enable 
this response, option 2 (uncertain) and 3 (dissatisfied) 
were merged. All models were adjusted for age, sex, and 
pre-operative PROM values. For both Paper I and II a 
separate linear regression analyses were conducted to 
investigate whether the time between surgeries had any 
association with the outcome. In Paper II, a sub-analysis 
was conducted in which an investigation was made to 
determine whether the influence of  type of  surgery 
(decompression, decompression with fusion or fusion 
alone) had any association with the outcomes. 
In Paper I and II the pre-operative values were modeled 
in piecewise-linear regression splines that corrects to a 
certain extent the ceiling effect and with predicted post-
operative values more likely in appropriate range (146).
Paper III
Any association with previous surgery was investigated 
using linear regression for the EQ-5D index and the 
EQ VAS score. Logistic regression models were applied 
after unifying answers 2 and 3 for the separate EQ-5D 
dimensions. The regression models were adjusted for 
sex, age, preoperative PROM scores and time between 
surgeries.
Paper IV
Cox regression analysis was used to investigate the 
association between postoperative PROMs, Charnley 
class, age and sex with reoperation, the model was 
adjusted for postoperative PROMs, age and sex. 
Investigation was made up to eight years following 
THR, after this there were too few reoperations to 
perform accurate analyses.
Paper V
Univariable ordinary least squares (OLS) regression 
models were used to estimate EQ VAS values for the 
different levels of  severity of  each dimension. For the 
preoperative EQ-5D-3L estimate, the preoperative EQ 
VAS score was regressed onto the preoperative EQ-
5D-3L dimensions. For the preoperative EQ-5D-5L 
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estimate, the preoperative EQ VAS score was regressed 
onto the preoperative EQ-5D-5L dimensions. This 
calculation with use of  postoperative data was repeated 
for estimation of  the postoperative values.
Prevalence calculation
In Paper I, prevalence of  an LSS prior to THR was 
calculated as the ratio of  patients identified with 
previous LSS surgery divided by the total number of  
patients with osteoarthritis operated with THR in 2012.
Prediction models
In Paper IV the predictive power of  PROMs one year 
postoperatively was evaluated by the concordance index 
(C) (149) (Figure 9). This value ranges from 0.5 to 1, 
with values closer to 1 representing a better score. A 
value of  0.5 means that PROMs are unable to predict 
the risk of  reoperation, while a value of  1 indicates that 
reoperation could be completely predicted by the model.
Figure 9. Concordance index
Figure 10. Possible distribution of  responses between 3L and 5L versions of  the EQ-5D.
Reoperation probabilities
In Paper IV, Kaplan-Meier curves were used to 
summarize reoperation probabilities
Response rates
In Paper V, response rates were calculated for the pre- 
and postoperative 3L and 5L versions of  the surveys for 
the whole group of  patients and for individual hospitals. 
Differences in response rates were then compared 
between the 3L and 5L questionnaires, both pre- and 
postoperatively. For those patients who completed both 
questionnaires (pre- and/or one year postoperatively), the 
3L and 5L responses were compared by dimension. The 
definition of  responses was determined as the same, new 
or inconsistent (inconsistent was regarded as a change by 
two levels or more between the surveys (150) (Figure 10). 
Ceiling and floor effects
In Paper V, ceiling effects were investigated by calculating 
the proportion of  responses of  “no problems” in indi-
vidual dimensions. Overall ceiling effects were investigated 
by calculating the proportion of  patients reporting “no 
problems” in all dimensions. An investigation of  floor 
effects was made by calculating the proportion of  patients 
with “extreme problems” in individual dimension and 
overall. Ceiling and floor effects were considered present 
if  > 15% of  patients reported the best (ceiling) or worst 
(floor) response option (151).
Correlations
In Paper V, Spearman´s rank correlation coefficient (rs) 
was used to determine the convergence of  the two EQ 
VAS survey scores. The correlation strength between 
the two surveys was defined as absent (rs < 0.20), weak 
(0.20 ≤ rs < 0.35), moderate (0.35 ≤ rs < 0.50), or strong 
(rs ≥ 0.50) (152).
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Paper I
The linkage involved 121,564 patients in the SHAR 
operated on from 2002–2013 and 43,767 patients 
in Swespine operated on from 1998–2014. Patients 
common in both registers were identified using the PIN. 
Following a stepwise selection process a study group 
of  997 patients and a matched control group of  997 
patients were obtained. One year after THR, patients 
with a previous LSS reported more pain, worse EQ-5D 
index, worse health status according to the EQ VAS 
and less satisfaction (all p<0.001). This relationship was 
confirmed with regression analyses (Table 2). We found 
no association with time between surgeries and PROs 
one year after THR adjusting for sex and age (r=0.11, 
p=0.0001).
Among patients with hip osteoarthritis who underwent 
THR in 2012, the prevalence for a previous LSS was 
3.5%. Of  these patients 40% had their LSS less than two 
years before THR (Figure 2).
Summary of papers
Paper II
From 2002 to 2012, there were 126,752 patients with 
THRs in the SHAR and 25,394 patients with LSS in the 
Swespine. Following linkage of  the registers common 
patients were identified using PINs as a common 
identifier. Following exclusion according to the selection 
criteria presented in Figure 2, a study group of  220 
patients with THR prior to their LSSS was identified. 
A matched control with no history of  a previous 
THR was successfully identified for each patient in the 
study group (Table 3). Linear regression confirmed an 
association with THR prior to LSSS and more back pain 
one year following LSSS, but no other associations was 
revealed by linear or logistic regression (Table 4).
In two separate linear regression analyses there were no 
associations with time between the surgeries or the type 
of  surgery and patient-reported outcomes (Table 5).
Table 2.  The effect of prior lumbar surgery on patient reported outcome measures (PROMs) 
one year after total hip replacement (THR). Crude values are from equations regressing 
lumbar spine surgery on post-operative PROMs, adjusted values take into consideration 
pre-operative PROM values, age and gender. The table present regression coefficients 
and associated 95 % confidence intervals.
Crude Adjusted
Pain VAS 4.33
(2.53; 6.12)
4.35 
 (2.57; 6.12)
EQ-5D Index -0.08 
(-0.11; -0.06)
-0.08 
(-0.11; -0.06)
EQ VAS -6.79 
(-8.68; -4.90)
-6.75 
 (-8.58; -4.92)
Satisfaction VAS 6.04 
(4.05; 8.03)
6.04 
(4.05; 8.02)
VAS, visual analogue scale
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Table 3.  Demography and pre-operative LSSS patient-reported outcome measures  
in the study group and the matched control group.
Control group  
(n=220)
Study group  
(n=220)
p-value
Age, mean (SD) 72.0 (8.7) 72.2 (7.8) 0.81
Sex, n (%) Female 118 (53.6) 115 (52.3) 0.85
Male 102 (46.4) 105 (47.7)
Year of surgery, mean (SD) 2010.4 (1.9) 2010.3 (1.6) 0.70
Type of surgery, n (%) Decompression 170 (77.3) 171 (77.7) 0.99
Decompression + fusion 49 (22.3) 48 (21.8)
Fusion 1 ( 0.5) 1 ( 0.5)
Diagnosis, n (%) Central spinal stenosis 
without olisthesis
158 (71.8) 163 (74.1) 0.67
Central spinal stenosis with 
olisthesis
62 (28.2) 57 (25.9)
EQ-5D index, mean (SD) 0.36 (0.32) 0.38 (0.31) 0.55
Mobility, n (%) 1 20 (9.1) 11 (5.0) 0.15
2 199 (90.5) 209 (95.0)
3 1 ( 0.5) 0 (0.0)
ADL/self-care, n (%) 1 188 (85.5) 184 (83.6) 0.86
2 29 (13.2) 33 (15.0)
3 3 ( 1.4) 3 (1.4)
Usual activities, n (%) 1 71 (32.3) 81 (36.8) 0.46
2 124 (56.4) 111 (50.5)
3 25 (11.4) 28 (12.7)
Pain, n (%) 1 2 (0.9) 1 (0.5) 0.80
2 107 (48.6) 111 (50.5)
3 111 (50.5) 108 (49.1)
Anxiety/depression, n (%) 1 99 (45.0) 122 (55.5) 0.05
2 109 (49.5) 92 (41.8)
3 12 ( 5.5) 6 (2.7)
EQ VAS, mean (SD) 49.6 (22.4) 48.8 (22.5) 0.72
Back pain VAS, mean (SD) 60.4 (24.8) 59.0 (25.9) 0.55
Leg pain VAS, mean (SD) 60.0 (25.0) 58.9 (26.0) 0.65
ODI score, mean (SD) 44.1 (15.7) 44.5 (14.8) 0.79
SD; standard deviation, VAS; visual analogue scale, ADL; Activities of  daily living, ODI; Oswestry Disability Index, 
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Table 4.  The effect of prior THR on PROMs one year after LSSS surgery. Crude values  
are from equations regressing LSSS on post-operative PROMs, adjusted values  
take into consideration pre-operative PROM values, age and gender of the patients. 
Crude Adjusted
EQ VAS -3.25 
(-7.50; 1.01)
-2.97
(-6.90; 0.97)
Back pain VAS 4.65 
(-0.79; 10.08)
5.30*
(0.27; 10.33)
Leg pain VAS 1.22 
(-4.43; 6.86)
1.52 
(-4.00; 6.99)
EQ-5D Index 0.01
(-0.05; 0.07)
0.06
 -0.05; 0.06)
ODI-score 2.81
(-0.71; 6.33)
2.58 
(-0.47; 5.63)
Satisfaction (OR) 1.07
(0,73; 1.58)
1.07
(0.72; 1.59)
EQ VAS, back and leg pain VAS, EQ-5D index and ODI are performed using linear regression 
analysis. Satisfaction are performed using logistic regression analyse. THR; Total hip replacement, 
LSSS; Lumbar spinal stenosis surgery, PROM; Patient-reported outcome measurement, OR=odds 
ratio. VAS; visual analogue scale, ODI; Oswestry Disability Index.  
*A value for linear regression that does not cross 0 is equivalent to significance.
Table 5.  The effect of type of LSSS in comparison with  
decompression on PROMs one year after LSSS.
Decompression + fusion Fusion
Crude p-value Adjusted p-value
EQ VAS 2.64
(-2.62;7.89)
 0.33 7.75 
(-24.39;39.89)
0.64
Back pain VAS -1.81
(-8.25;4.62)
0.58 -1.09 
(-40.44;38.26)
0.96
Leg pain VAS 0.52 
(-6.40;7.44)
0.88 -1.52 
(-43.84;40.81)
0.94
EQ-5D Index 0.02 
(-0.05;0.09)
0.54 0.02 
(-0.38;0.42
0.91
ODI-score -0.15 
(-4.33;4.02)
0.94 -3.28 
(-28.80; 22.24)
0.80
Satisfaction -0.04 
(-0.20;0.12)
0.60 0.52 
(-0.45;1.49)
0.30
The table present regression coefficients and associated 95 % confidence intervals. EQ VAS, back and leg pain VAS, EQ-5D 
index and ODI are performed using linear regression analysis. Satisfaction are scored using logistic regression analysis. VAS; visual 
analogue scale, ODI; Oswestry Disability Index 
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Paper III
A linkage procedure was performed using the same 
SHAR- and Swespine datasets from 2002 to 2012, as in 
Paper II. Common patients were identified using PINs. 
Two study groups were successfully identified with LSSS 
prior to THR (n=171) and THR prior to LSSS (n=84). 
Linear regression analysis revealed an association with 
Table 6.  Linear regression analysis with association of first LSSS with PROMs 
one year after surgery. Crude values are from equations regressing LSSS  
on post-operative PROMs, while adjusted values take into consideration  
pre-operative PROM values, age and sex of the patients and time  
between surgeries. 
Crude Adjusted
EQ-5D Index 0.09*
(0.02; 0.16)
0.09*
(0.03; 0.16)
EQ VAS 5.59* 
(0.14; 11.05)
5.61*
(0.36; 10.86)
The table present linear regression coefficients and associated 95 % confidence intervals. VAS; 
visual analog scale, *a value for linear regression that do not cross 0 is equivalent to significance
Table 7.  Logistic regression analysis of the association of first LSSS with PROMs  
one year after surgery. Crude values are from equations regressing LSSS on  
post-operative PROMs, while adjusted values take into consideration pre-operative  
PROM values, age and sex of the patients and the time between surgeries. 
Crude Adjusted
Mobility 1.53 
(0.88; 2.73)
1.52
(0.86; 2.72)
Self-care 1.57 
(0.67; 3.56)
0.97
(0.35; 2.59)
Usual activities 1.42 
(0.83; 2.42)
1.51 
(0.88; 2.62)
Pain 3.00*
(1.55; 6.22)
3.01*
 (1.54; 6.29)
Anxiety/depression 1.99*
(1.13; 3.48)
2.26* 
(1.25; 4.14)
The table present logistic regression coefficients and associated 95 % confidence intervals, *a value for 
logistic regression that do not cross 1 is equivalent to significance
LSSS prior to THR and a better outcome in the EQ-5D-
index and EQ VAS (Table 6). Using logistic regression 
analysis, LSSS prior to THR also revealed an association 
with a better outcome for the separate dimensions of  
“pain” and “anxiety/depression” (Table 7). 
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Paper IV
Of  the patients included according to the selection 
criteria, the prosthesis survival rate at the ten-year 
follow-up was 95.5 % (95.3–95.8). The mean time until 
reoperation was 1589 days (SD 887 days). Cox regression 
modelling revealed an association with PROMs for the 
risk of  reoperation with pain (B=1.01, 95% CI: 1.01, 
1.02), satisfaction VAS (B=1.02, 95% CI: 1.01, 1.02), 
and the EQ-5D-index (B=0.64, 95% CI: 0.49, 0.85), 
but none for the EQ VAS (B=1.00, 95% CI: 0.99, 
1.01). The Cox regression also revealed an association 
for the risk of  reoperation with age (B=0.98, 95% CI: 
0.97, 0.98), sex (female B=0.71, 95% CI: 0.64, 0.79), 
and Charnley class B (B=0.75, 95% CI: 0.62, 0.91), and 
C (B=0.83, 95% CI: 0.73, 0.94) (Table 8). Satisfaction 
VAS (C=0.650) and pain VAS (C=0.649) had the highest 
predictive powers (Table 8). It was possible to construct 
a model for predicting the risk of  future reoperation, 
with a concordance index of  0.68. There was only a 
marginally difference between observed reoperations 
and predicted reoperations using the predictive model. 
If  further information were put into the model, it could 
possibly be used to construct an automatized system 
for the detection of  patients running a higher risk of  
reoperation following THR. The way different levels 
of  PROMs affect the probability of  being reoperated 
following THR is presented in Figure 11. 
Table 8.  Association of postoperative PROMs, Charnley class, age and sex with reoperation  
using Cox regression adjusted for age, sex and postoperativ PROMs. Predictive power  
of postoperative PROMs, Charnley class, age and sex with reoperation. 
Variables HR 95% CI lower 95% CI upper C
Charnley class A Ref 0.539
Charnley class B 0.752 0.623 0.909
Charnley class C 0.829 0.728 0.943
Pain VAS 1.014 1.011 1.017 0.649
EQ VAS 1.001 0.998 1.005 0.602
Satisfaction VAS 1.016 1.013 1.018 0.650
EQ-5D index 0.643 0.489 0.846 0.607
Age 0.975 0.970 0.980 0.566
Male Ref 0.535
Female 0.713 0.641 0.793
HR = hazard ratio, 95% confidence interval 
C =concordance index
Figure 11. Probability of  being reoperated. 
Cox regression survival estimates for the average patient (average 
baseline characteristics and one-year PROMs), a patient with 
good PROs (no hip VAS pain, full satisfaction, EQ mobility=1 
EQ pain/discomfort=1) and a patient with poor PROs (hip 
VAS pain=50, satisfaction VAS=50, EQ mobility=2, EQ 
pain/discomfort=2).
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Figure 12. Distributions of  answers between 3L and 5L-surveys for all patients
Same is the same answer option between 3L and 5L. New is one step from 3L to 5L. Inconsistent is two or more steps from 3L to 5L.
Paper V
The response rates were lower than expected for both 
surveys both pre- and postoperatively (Table 9).
A large proportion of  the patients used new response 
options preoperatively in the mobility (61%), self-care 
(41%), usual activities (46%), and pain/discomfort 
(54%) dimensions in the 5L version compared with the 
3L version (Figure 12). One year postoperatively most 
patients reported no problems in all dimensions for both 
versions of  the survey, (3L 32%, 5L 25%). Inconsistent 
answers were most frequently reported preoperatively 
and then in the separate dimensions on self-care (17%) 
and usual activities (20%) (Figure 12). 
There were limited ceiling effects in each version 
preoperatively. Postoperatively, all dimensions in both 
versions presented ceiling effects but to a lesser degree 
in the 5L version. The overall ceiling effect differed 
by seven percentage units postoperative. Floor effects 
were only present in the preoperative pain/discomfort 
dimension of  the 3L survey. 
The correlations between the 3L and 5L EQ VAS values 
were strong: preoperatively rs = 0.71 and postoperatively 
rs = 0.87. 
The EQ VAS estimates for different severity levels of  
each dimension conformed well to the expected pattern 
(Figure 13 and 14), with the exception for preoperative 
mobility. Because of  the rarity of  level 4 and 5 responses 
in the EQ-5D-5L questionnaire, these two levels were 
merged. 
Table 9.  Total hip replacements performed in 2015 and  
preoperative response rate for the EQ-5D 3L and 5L surveys
Preoperative Postoperative
Clinic Tot. 3L 5L 3L and 5L Tot. 3L 5L 3L and 5L
All, n (%) 1567 1182 (75) 767 (49) 524 (33) 1554 1400 (90) 508 (33) 508 (33)
Preoperative 
Postoperative
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Figure 13. Preoperative regression of  the EQ-5D-3L and -5L 
surveys with the EQ-VAS for each dimension.
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Figure 14. Postoperative regression of  the EQ-5D-3L and -5L 
surveys with the EQ-VAS for each dimension.
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This section contains analyses and results of  the papers included in this thesis that have not been or are not 
intended to be included in the publications.
Additional results
Table 10.  Ceiling effects preoperative and one-year postoperative THR  
in patients with and without a previous LSSS.
Survey dimension Preoperative Postoperative
Only THR (n=997) LBS and THR (n=997) Only THR (n=997) LBS and THR (n=997)
Mobility 3.5 % 2.9 % 51.1 % 34.8 %
Self-care 67.6 % 68.2 % 89.1 % 87.1 %
Usual activities 30.8 % 25.0 % 72.5 % 59.7 %
Pain/discomfort 0.7 % 0.7 % 35.6 % 26.3 %
Anxiety/depression 48.9 % 48.9 % 73.5 % 66.1 %
Overall 0.3 % 0.1 % 28.2 % 18.8 %
Table 11.  Adjusted effect of prior lumbar surgery on patient reported outcome measures (PROMs) 
one year after total hip replacement (THR) following the exclusion of the 86 patients with LSSS prior 
to 2002. Crude values are from equations regressing lumbar surgery on post-operative PROMs, while 
adjusted values take into consideration pre-operative PROM values, age and gender. The table 
present regression coefficients and associated 95 % confidence intervals.
Crude Adjusted
Pain VAS 4.30
(2.54; 6.19)
4.30 
 (2.49; 6.11)
EQ-5D index -0.08 
(-0.10; -0.06)
-0.08 
(-0.10; -0.06)
EQ VAS -6.69 
(-8.61; -4.77)
-6.68 
 (-8.54; -4.82)
Satisfaction VAS 6.11 
(4.12; 8.14)
6.14 
(4.12; 8.16)
VAS, visual analogue scale
Paper I
In addition to the published results, ceiling effects 
of  EQ-5D-3L pre- and postoperative THR for both 
groups were investigated. The method used was the 
same as in paper V. As expected and in agreement with 
earlier reports, both groups presented profound ceiling 
effects at the follow-up (Table 10).
An additional regression analysis was also performed 
following the exclusion of  the patients with LSS 
performed prior to 2002 (n=86). The association 
with worse PROMs following THR in patients with a 
previous LSS did not change (Table 11).
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Paper II
As for Paper I an additional calculation for this thesis 
were made investigating the ceiling effects of  the EQ-
5D-3L pre- and postoperative LSSS for both groups. 
Postoperative ceiling effects were present in the only 
Paper III
The change in health-related quality of  life was 
investigated over time by analyzing differences from 
before to one year after the first procedure, one year 
after first procedure to before second procedure, and 
before and one year after the second procedure. Due 
to the fact that the preoperative measurement for the 
second procedure had to occur after the postoperative 
measurement following the first procedure, the number 
of  included patients was reduced to 67 (first hip) and 
69 (first spine). The largest improvement occurred from 
before to after the second procedure (Table 13 and 
14). This corroborates the results in paper III where 
preoperative first procedure to preoperative second 
procedure and pre- and postoperative second procedure 
was investigated.
A calculation was also made that presents the way the 
distribution of  time between the procedures takes place 
for the patients with both procedures performed within 
two years. Of  the patients with first an LSSS, 68 % 
(n=150) had their THR within one year. For the patients 
with first THR, it was 37 % (n=81) who had their LSSS 
within one year (Figure 15). 
LSSS group for all dimensions except “pain” and 
“overall”. For the group with both THR and LSSS 
ceiling effects were present in all dimension except for 
“mobility”, “pain” and “overall” (Table 12). 
Table 12.  Ceiling effects preoperative and one-year postoperative THR  
in patients with and without a previous LSS.
Survey dimension Preoperative Postoperative
Only LSSS (n=220) LHR and LSSS (n=220) Only LSSS (n=220) THR and LSSS (n=220)
Mobility 4.1 % 2.3 % 18.2 % 12.7 %
Self-care 38.6 % 38.2 % 38.6 % 38.6 %
Usual activities 14.5 % 16.8 % 27.3 % 25.9 %
Pain/discomfort 0.5 % 0 % 7.3 % 6.4 %
Anxiety/depression 20.5 % 25.0 % 29.5 % 28.2 %
Overall 0 % 0 % 5.9 % 5.0 %
Table 13.  Differences in PROMs for EQ-5D index 
and EQ VAS between interventions.
Period PROM First 
 procedure
Diff. (mean) p-value
1 EQ-5D Hip (n=67) 0.23 0.000
Spine (n=69) 0.20 0.000
2 EQ-5D Hip -0.18 0.000
Spine -0.25 0.000
3 EQ-5D Hip 0.27 0.000
Spine 0.37 0.000
1 EQ VAS Hip 9.30 0.034
Spine 11.91 0.000
2 EQ VAS Hip -9.57 0.006
Spine 8.06 0.017
3 EQ VAS Hip 17.27 0.000
Spine 19.03 0.000
Period 1 = pre and postoperative first procedure,  
2 = postoperative first procedure and preoperative  
second procedure,  
3 = pre- and postoperative second procedure
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Table 14.  Differences in PROMs for the separate dimensions of the EQ-5D between interventions.
Dimension Period first Diff. mean p-value
Mobility 1 Hip (n=67) -0.239 0.000
Spine (n=69) -0.130 0.022
2 Hip 0.224 0.000
Spine 0.174 0.001
3 Hip -0.284 0.000
Spine -0.319 0.000
Self-care 1 Hip -0.149 0.013
Spine 0.058 0.336
2 Hip 0.090 0.145
Spine 0.145 0.072
3 Hip -0.090 0.145
Spine -0.203 0.003
Usual activities 1 Hip -0.254 0.013
Spine -0.232 0.010
2 Hip 0.254 0.004
Spine 0.319 0.001
3 Hip -0.328 0.002
Spine -0.478 0.000
Dimension Period first Diff. mean p-value
Pain 1 Hip -0.478 0.000
Spine -0.420 0.000
2 Hip 0.403 0.000
Spine 0.449 0.000
3 Hip -0.522 0.000
Spine -0.725 0.000
Anxiety/ 
depression
1 Hip -0.060 0.564
Spine -0.101 0.133
2 Hip 0.060 0.362
Spine 0.072 0.236
3 Hip -0.075 0.261
Spine -0.188 0.030
Period 1 = pre and postoperative first procedure,  
2 = postoperative first procedure and preoperative  
second procedure,  
3 = pre- and postoperative second procedure
Figure 15. Percentage of  patients 
with both procedure performed 
within one-year.
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General limitations of studies based on register data
A register study can never be more valid than the register 
data it is based upon. Furthermore, the validity of  a register 
is dependent on the completeness and the coverage of  
the investigated variable in the register. In the SHAR 
the coverage is 100%, and the completeness of  THR 
registrations has been reported as 98.1 % (16, 107), for the 
Swespine the coverage is 98% and the completeness of  
registrations has been reported as 85% (2). Nevertheless, 
it is still important to remember that an observational 
register study can be used to investigate, explore and 
present correlations between exposure and outcomes, 
but it does not allow for the possibility of  determining 
causality. This is due to the fact, that in register studies 
there are no outside controls, there can always be hidden 
confounders and the risk of  bias. There are many possible 
confounders that could influence both the exposure and 
the outcome. Confounding factors can be patient related 
such as PROs, BMI, smoking, education, medical and 
psychiatric comorbidity or surgery related, such as surgery 
time, bleeding, implant (type, fixation, positioning) and so 
on. In all surgery such as orthopedic surgery, the surgeon 
may also have an influence on the outcome. There are 
also many possible biases in observational studies such as 
register studies. Examples of  different types of  bias are 
selection bias, detection bias, reporting bias, performance 
bias, and attrition (115). Despite these limitations, register 
studies have an important role when clinical trials are not 
possible to conduct due to high costs, necessary number 
of  patients and length of  observation period. 
Specific strengths and limitations regarding paper I-III
The large number of  patients in the study population 
and the precise matching procedure of  patients add 
to the strengths of  Paper I-II. The thorough selection 
procedure in all studies was also designed to reduce 
confounding bias and heterogeneity. In Papers I 
and II, matching procedures was based not only on 
demographic variables, year of  surgery and details 
of  the surgical method but also on the patients´ self-
reported pain level, health-related quality of  life and 
in Paper I also Charnley class. The data for all three 
studies comes from two well-established and thoroughly 
validated national quality registers. They could therefore 
be considered to reflect the general orthopedic practice 
in Sweden and this limits performance bias and increases 
generalizability. 
Strengths and limitations
Paper III only investigated outcomes common in 
both registers (EQ-5D and EQ VAS), which restricts 
the possibilities of  comprehensive analyses. It was not 
possible to investigate pain (except for the separate 
“pain” dimension of  the EQ-5D) or satisfaction with 
the outcome. Both these outcome variables are of  
course important since pain and satisfaction with the 
outcome is of  utmost importance in this type HRQoL 
improvement procedures. 
The observational nature of  the data from these two 
national quality registers prevents the drawing of  
conclusions relating to causality. The analyses were 
restricted to investigating the outcomes in patients with 
both THR and LSS compared with matched controls 
with no documented history of  LSS or THR due to a 
degenerative spinal disorder and or hip OA and patients 
with both THR and LSS within a short period of  time. 
In Paper III the assumption was made that the patients 
had degenerative diseases in both locations prior to 
surgery due to the short time between surgeries, but this 
is not known. Another limitation applicable for Papers 
I-III, is the possible influence of  other musculoskeletal 
conditions such as knee osteoarthritis or presence of  joint 
replacement in other locations. Other non-musculoskeletal 
comorbidities such as diabetes or cardiovascular diseases 
were not adjusted for and this could be regarded a 
limitation. The follow-up period of  one year is also 
relatively short, it is possible that the differences will adjust 
over time. Analyses were restricted to the data available 
in registries. Other clinical measures, such as radiographic 
severity or abnormalities were not available. 
There are differences between the three studies regarding 
the inclusion of  spinal diagnoses. In all three studies 
we included central and lateral spinal stenosis with and 
without olistehsis. However, in Paper I we also included 
spondylolisthesis/spondylolysis and segment related 
pain. Discussion within the research group following the 
completion of  Paper I resulted in the decision to exclude 
spondylolisthesis/spondylolysis and segment related 
pain in the further studies as these diagnoses differ in 
origin, symptoms and progress and in relationship with 
hip OA. However, the inclusion of  these diagnoses in 
Paper I did not have any practical consequences for the 
interpretation of  results since these two diseases were 
present in only 8% of  the population.
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Specific considerations regarding paper IV
In comparison with earlier studies investigating the 
predictive power of  different patient-reported variables, 
a substantially larger number of  patients were included 
in the calculation of  this study. In contrast to most 
previous studies, several PROMs have been taken into 
consideration when performing the analysis. Patients 
were selected in order to reduce confounding biases 
and provide a homogenous group to investigate. The 
previously described studies presenting patient-related 
factors (22–25) and PROMs (26–28) to predict the 
risk of  future revision following THR have used OR 
(odds ratio) and HR (hazard ration) to predict the 
risk of  revision. However, these methods have been 
declared unsuitable for these conclusions since they 
lack predictive strength (153). Together with a Cox 
regression analysis, an analysis using the concordance 
index method was conducted in paper IV. This provides 
a substantially higher power to the predictive power of  
the analyses than earlier reports.
There are limitations to this study. Factors other than 
poor PROMs, such as high BMI and long surgery time, 
contribute to the risk of  reoperation (22–25). These 
confounders have not been analysed or adjusted for in 
this model, simply due to the lack of  such information. 
The models presented in this study only included one-
year PROMs and before the construction of  a model to 
scan the register in order to detect these patients there 
is a need to add further patient data, surgical data and 
longer follow-ups. Furthermore, patients not returning 
the PROMs questionnaires might also have a poorer 
outcome and there are also of  course patients in the 
model with an estimated low risk who will need a future 
reoperation, but these will not be detected by a system 
of  this kind.
Specific considerations regarding paper V
Time span of  two weeks between the distributions of  
the surveys could be considered a limitation. The most 
commonly used method to investigate differences 
between the three- and five-level surveys of  the EQ-
5D is to administer both surveys at the same sitting, 
commonly with other surveys in-between the two 
versions (132, 136, 154). However, it has been shown that 
patients have a tendency to avoid using the intermediate 
options in the five level survey if  the three level 
version is administered first in the same sitting (150). 
In an attempt to avoid this possible bias, we decided to 
administer the two surveys with a two-week time-span 
in between. Due to the natural changes in hip symptoms 
the time span likely contributed to the inconsistency in 
the responses in the EQ-5D dimensions of  “mobility” 
and “pain”. 
Another limitation is the various response rates between 
the different hospitals. There are no explanations for 
this since demographic do not differ and no other 
reasons are apparent. At all hospitals except one, both 
the preoperative- and postoperative response rate for 
the three level version are close to the average response 
rate of  the EQ-5D 3L in the Swedish Hip Arthroplasty 
Register, above 90% (16, 107). This is a considerably 
higher response rate of  the survey than in similar 
studies (9, 10). When comparing to a study investigating 
preoperative differences in the three- and five level 
versions of  EQ-5D in a THR and knee replacement 
population the preoperative response frequency of  the 
five level version is similar (10).
Another limitation of  this study is that in comparison 
with other studies that constructs value sets, is the 
low number of  included patients. However, since the 
purpose of  this study was to construct a provisional 
estimation regarding a Swedish THR-population, 
the number of  included patients is acceptable for its 
purpose. 
The calculated estimate between the EQ-5D-3L and 
5L with EQ VAS that is developed in this study is only 
applicable to a Swedish total hip replacement population. 
Therefor, these results are limited for this use and cannot 
be applied in other diagnoses or populations.
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General discussion 
The common feature for all the papers in this thesis is 
the assessment of  the clinical utility of  PROMs in total 
hip replacement surgery, and for Papers I-III in lumbar 
spine surgery. PROMs have been used and investigated 
in several different ways, using different methods.
In general, all patients in Paper I to III reports better 
outcome following surgery, in HRQoL, pain or 
satisfaction with the outcome, regardless of  whether 
this relates to LSS/LSSS or THR. It is however 
apparent that patients undergoing surgery in both the 
hip and spine due to degenerative disorders have a 
poorer outcome than patients with only surgery in one 
of  the locations. It appears that patients in whom both 
surgeries are performed within a short time are better 
off  starting with LSSS. It is also apparent that PROMs 
can be used to detect patients running a higher risk for 
reoperation. Moreover, the knowledge that the new five 
level version of  the EQ-5D better assesses the outcome 
following THR adds to a possible improved detection 
of  changes in the care of  the THR-population. 
The results presented from the studies in this thesis add 
to the knowledge regarding patients with THR and LSS 
procedures performed. Moreover, this knowledge can 
be used for investigations for better planning for time 
of  surgery, to prevent or detect complications and to 
provide a better understanding of  the expected outcome 
of  surgery. Potentially, this may help reduce suffering 
and pain among patients with degenerative diseases 
eligible surgical interventions to hip and lumbar spine.
The clinical assessment of PROMs  
following THRs and LSSs
The numbers of  patients with need for both THRs and 
LSSs will continue to increase for many years to come 
(1, 2). In time this will also contribute to an increase 
in the number of  patients undergoing both procedures 
and also contribute to a larger number of  patients 
requiring late reoperations. All these circumstances will 
increase the pressure on health-care resources, not only 
in Sweden but also internationally.
Discussion
Patient-reported outcome measures following surgery 
in patients with both total hip replacement and lum-
bar spine surgery
In Papers I and II, patient-reported outcomes following 
THR and LSS are worse for patients with both 
procedures performed compared to patients with only 
one of  the procedures performed. Musculoskeletal 
comorbidity has been reported to be associated with 
worse patient-reported outcomes following both THR 
(78, 155) and LSS (83, 84). It is therefore not surprising 
that patients with surgery-dependent degenerative 
diseases in both the hip and lumbar spine had poorer 
outcomes following THR and LSS compared to patients 
with an isolated total hip replacement or lumbar spine 
surgery. Furthermore, when comparing the results 
between Paper I and II, LSS prior to THR appeared 
to have worse outcomes than the controls for all 
outcome variables, as opposed to those with LSS after 
a previous THR who “only” had worse outcomes in 
back pain. When the two studies are compared in more 
detail, the emphasis is on the postoperative EQ-5D 
index and EQ VAS values, as these are the comparable 
outcome measures between the two studies, similar to 
what was done in paper III. The investigation of  the 
preoperative variables for EQ-5D index and EQ VAS 
reveals differences between Paper I and II. Prior to 
THR in Paper I, the scores for EQ-5D index and EQ 
VAS were 0.29 and 47.9, respectively, and for Paper II 
the preoperative values prior to LSS were 0.38 and 48.8 
(Tables 2 and 5). The postoperative results for Paper I 
showed a mean EQ-5D index of  0.66 and EQ VAS of  
66.3 (Δ 0.37 and 18.4) and for Paper II 0.62 and 61.8 
respectively (Δ 0.24 and 13) (Tables 3 and 6). Comparing 
these studies, the LSS prior to THR group from Paper I 
had better outcomes than the THR prior to LSS group 
from Paper II, but worse preoperative scores and less 
improvement when compared to patients with only 
THR and LSS respectively. 
Paper I and II contributes to the knowledge of  the 
influence of  previous surgery due to degenerative diseases 
in the lower back and hip. Importantly, the combination 
of  spine and hip problems prior to LSS or THR surgery 
predispose worse patient-reported outcomes regardless 
of  surgical order. However, patients with LSS prior to 
THR appear to have a less favorable result compared to 
patients with THR prior to LSS. However, it is important 
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to mention that there is a difference in the type of  pain 
originating from degenerative diseases from the hip and 
lumbar back. The majority of  the pain from hip OA is 
nociceptive while pain from lumbar spinal stenosis (which 
is the majority of  the patients with LSS performed) is 
neuropathic. This difference in pain mechanism may 
partly explain why patients with lumbar condition to a 
larger extent develop chronic pain. Likely, the instruments 
used are less do not detect such differences. Therefore, the 
pain measured is somewhat different in its presentation 
and could probably reflect the differences in outcome in 
some aspect. 
However, patients likely benefit from being informed 
about the possibility that they might require two different 
operations to treat their combined symptoms (91). This 
knowledge about the risk of  less improvement in the 
expected outcome in patients with a known comorbidity 
should be considered in the shared decision-making 
process in patients eligible for THR and LSS procedures, 
and it may help communication in order to set proper 
expectations for the outcome following total hip 
replacement and lumbar spine surgery.
Ceiling effects following lumbar spinal surgery and 
total hip replacement
Ceiling effects are a known limitation of  the EQ-5D-3L 
following several procedures (156). In the papers included 
into this thesis this has been investigated in Paper V. In 
this thesis investigation has also been conducted if  this 
limitation is also apparent in Papers I and II. As predicted 
in Paper I there are ceiling effects with the outcome for all 
dimensions of  the EQ-5D. In paper II on the other hand 
the ceiling effects are less apparent but still in a majority of  
the dimensions. In the group with both THR and LSSS it 
is not surprising that there is less observed ceiling effect in 
the “mobility” dimension since patients with degenerative 
disease in multiple locations could be considered to have 
greater walking impairment. Nevertheless, the presence 
of  ceiling effects presented in paper I, II and V points 
at this complication with the EQ-5D instrument 
that reduces the possibility to detect changes of  care 
following orthopedic surgical interventions such as total 
hip replacement and lumbar spine surgery. The reduction 
of  ceiling effects presented with the use of  EQ-5D 5L 
version in Paper V could be expected to be present in 
Paper I if  used there as well. This could possibly also be 
expected if  implemented into the Swespine in the future. 
In addition, the results in Paper V reveal that the use of  
the EQ-5D-5L reduces not only ceiling effects, it is also 
more sensitive and provides a deeper descriptive richness 
following THR. It also demonstrates a strong correlation 
of  the EQ VAS tool administered in the two surveys and 
that the valuation of  the different response option from 
the two versions follow a consistent pattern. The results 
indicate that the new version of  the EQ-5D provides 
more accurate information of  the outcome following 
THR. This may facilitate the assessment of  health care 
interventions and improvements in care processes and 
provides a more fine-granular tool to identify areas to 
improve. This is especially important since THR is an 
elective procedure with the main purpose to reduce 
pain, gain mobility and improve HRQoL. 
Shifting to the EQ-5D-5L may improve the assessment 
of  clinical outcomes following both total hip 
replacement and lumbar spine surgery. 
PROMs as predictors of the risk of late reoperation
As presented in Paper IV, PROMs collected one-year 
after THR can predict the risk of  future reoperation. This 
has a substantial possibility to improve the clinical care of  
this group of  patients running an increased risk of  future 
revision. This knowledge could be used to monitor these 
patients intensively and deal with their symptoms and 
complications following THR at an earlier stage, thereby 
shortening their suffering. This has the potential not 
only to reduce patient suffering, but also to save health-
care resources that could be used elsewhere. The model 
in our study can also be used to estimate individualized 
reoperation probabilities at different time intervals. This 
could be used in the process of  developing a warning 
system to indicate patients running a high risk of  future 
revision following THR. Since the completeness of  the 
register is about 98.1% (16, 107) almost all patients at 
increased risk for reoperation could be detected. To do 
so, future studies need to be performed with an increased 
input of  data to the model. A delicate challenge of  that 
work will be to determine the threshold for acceptable 
and not acceptable levels of  increased risks.
The hip-spine syndrome -where to 
start with surgery, the hip or the spine?
Since the “hip-spine syndrome” was defined by Ofierski 
et al in the late 1970s, there has been an ongoing 
discussion were to perform surgery first in patients with 
known symptomatic degenerative disease in both the 
hip and lumbar spine. 
The results from Paper III suggested, for patients who 
receives both THR and LSSS procedures within a short 
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period of  time, that those who first receives a LSSS have 
better final HRQoL outcomes compared to the opposite 
order. The results also demonstrated that the most 
improvement occurred between the pre- and postoperative 
time points for the second procedure, regardless of  in 
which location the first surgery was performed. However, 
a higher improvement was seen for the group where LSSS 
where performed as the first procedure. This implies that 
both surgeries were indicated and needed in order to gain 
improvement in HRQoL and pain measurements. Only 
considering the results from paper III, one may conclude 
that it is preferable to start with LSSS if  surgery is indicated 
in both locations. However, there are other aspects that 
are needed to be taken into consideration before such a 
conclusion can be drawn. 
Firstly, we looked at the number of  patients treated. In 
Paper III, it is twice as common to start with LSSS and 
then go on with a THR (n=171) than to start with THR 
and then receive a LSSS (n=84). This difference was also 
observed when considering the number of  patients in 
the study groups of  Paper I and II. In Paper I there were 
997 patients with LSSS prior to THR compared to 220 
patients with THR before LSSS in Paper II. Some of  these 
differences in number of  procedures might be explained 
by the different time-periods of  inclusion between paper 
I and II-III. In Paper I, the included years from Swespine 
was 1998–2012 compared to 2002–2012 in Paper II and 
III. More spinal diagnoses was also included in Paper 
I than in Paper II and III. After adjustments of  the 86 
patients in paper I with LSS prior to 2002 (central spinal 
stenosis with and without olistesis n=64, lateral spinal 
stenosis n=12, lumbar spondylosis/spondylolisthesis 
n=5, and segment related pain n=5), and the patients with 
lateral spinal stenosis (12%, n=120), lumbar spondylosis/
spondylolisthesis (4%, n=38) and segment related pain 
(4%, n=41), in total 285 patients, there are 712 patients 
with THR following LSSS. Even after this adjustment, 
there were almost three times as many patients that 
received a THR following LSSS than the opposite. 
Secondly, we looked at time between surgeries. In Paper 
III there is a difference in time between surgeries, where 
the time-period between LSSS first and THR second is 
significantly shorter than the opposite. Of  those with 
both procedures performed within one year, around 68% 
of  the patients with first LSSS had their THR performed 
within one year, in contrast to those with first THR where 
only about 37% received their LSSS within the first year 
(Figure 16). However, this could be due to that THRs have 
been more accessible in Sweden the last decades. There 
is also a time difference between the surgeries between 
Paper I and II, with 3.27 years between surgeries if  LSSS 
first and 3.0 years if  THR first, a difference of  almost 
four months. So, the time differences between hip first 
and spine first appears to be reduced over time. However, 
there were differences in these studies where there were 
patients with LSSS procedures performed from 1998 
that could affect this time. Despite these comparisons, it 
is also important to note that there were no significant 
differences in postoperative PROs when time between 
surgeries was investigated separately in any of  the Paper 
I-III, so these time differences between surgeries less 
likely play any major role for the result obtained.
Thirdly, we compare the outcomes in the two groups in 
Paper III with the outcomes of  the study groups in Paper 
I and II. Again, only EQ-5D index and EQ VAS were 
compared since these are the only common PROMs 
between the three studies. In Paper III, there were no 
significant difference between the groups preoperatively. 
Postoperatively, there were significant differences where 
LSSS prior to THR had an outcome at EQ-5D index 
of  0.72 and EQ VAS 72.2, compared with THR prior to 
LSSS with 0.63 and 65.6. If  these results are compared 
with the previous Paper I and II, we can see that the 
preoperative values for LSSS prior to THR in Paper III 
are similar to those for LSSS prior to THR in Paper I, and 
the values for THR prior to LSSS in Paper III are slightly 
higher than THR prior to LSSS in Paper II. However, 
the postoperative values for the LSSS prior to THR in 
Paper III are almost the same as the group with only 
THR in Paper I. So, this group with LSSS prior to THR 
performed within a short period of  time almost have the 
same outcome in EQ-5D index and EQ VAS as a group 
with only THR procedure. For both groups in Paper III 
the improvement occurred in the time period between 
pre- and postoperative measurements of  the second 
procedure. If  the delta values of  EQ-5D index and EQ 
VAS between before and after the second procedure from 
these groups were compared to those in the groups with 
both THR and LSS/LSSS from Paper I and II, we see an 
interesting relationship. In Paper I, the delta value pre and 
post THR in the LBS prior to THR group was Δ0.37 for 
EQ-5D index and Δ18.4 for EQ VAS. These values are 
very similar to the difference in the LSSS prior to THR 
group in paper III, with a pre- to postoperative difference 
of  Δ0.37 in EQ-5D index and Δ19.3 in EQ VAS. In Paper 
II, the THR prior to LSSS group had pre- and post LSSS 
EQ-5D index changes of  0.24 and for EQ VAS 13 units. 
This was a slightly less improvement compared to Paper 
III where the THR prior to LSSS group had a change EQ-
5D index of  0.27 and in EQ VAS of  17.27. Comparing 
results of  these studies, all groups had improvement 
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following their last procedure but LSS prior to THR had a 
better improvement overall in both EQ-5D and EQ VAS. 
It is important to mention that these comparisons cannot 
be determined to be significant or not, just generally 
compared. However, the observations could be due to that 
the surgery of  the hip and lumbar spine alone respectively 
had less effect on the symptoms, hence these patients 
strongly benefit by the following THR or LSS procedure 
and reflects that the patients were in the need of  both 
procedures due to combination of  degenerative diseases. 
Lastly, we searched the literature for reports of  
complications following surgery in patients with known 
LSS and THR performed. The literature presents several 
studies reporting that complications following THR 
increases if  there is a previous lumbar spinal fusion 
performed (157–162). There is also one study presenting 
that the risk is higher for complication after THR if  spinal 
fusion is performed after THR (161). However, there 
are no reports of  complications following spinal surgery 
in patients with previous THR. Not surprisingly, these 
reports take account of  the change occurring in pelvic 
position and less flexibility following lumbar spinal fusion. 
In a seated position, the pelvic assumes a more (posterior) 
pelvic tilt. On average this increases by 22º (176), 
which would result in approximately 15° increase in 
acetabular anteversion. This increase in anteversion 
reduces the risk of  dislocation due to improved posterior 
coverage of  the femoral head, and also by preventing 
anterior femoro-acetabular impingement. Spinal fusion 
to the pelvis prevents the lumbar spine from reducing 
lordosis and thereby increasing (posterior) pelvic tilt (171). 
Similarly, a patient with increased pelvic tilt due to spinal 
deformity will have less change in the postural variation 
in pelvic tilt. Since spinal deformity correction aims to 
increase lumbar lordosis, and reduce pelvic tilt with fixation 
and fusion. As a consequence, changes in spinal alignment 
will cause a change in acetabular anteversion. A decrease 
in pelvic tilt is accompanied by a decrease in acetabular 
anteversion, a change in the anterior pelvic plane by 1° 
changes acetabular anteversion by 0.7° (163). This imply a 
higher risk for dislocation of  the hip prosthesis following 
a lumbar spinal fusion. If  a spinal fusion is performed 
prior to THR, this changes in alignment and reduction 
in the flexibility of  the pelvis, which could be taken into 
consideration when positioning the acetabular cup.
It is probably impossible to create a golden rule for 
were to begin with surgery in patients with “hip-
spine syndrome”. However, if  we take the knowledge 
acquired from the studies in this thesis and the literature, 
an algorithm could be made as a help or guide in the 
decision-making process relating to the order in which 
to start, the hip or the spine, in the case of  degenerative 
disease in both locations. This algorithm is presented 
in Figure 16. Firstly, if  the patient has a location with 
more severe symptoms, it is logical to start with surgery 
in this location, even if  no strict scientific evidence for 
this exists. If  this is the hip and it is suspected that the 
patient will need a spinal fusion in the future in order 
to achieve spinal realignment, this needs to be taken 
into consideration when positioning the acetabular cup, 
or else fusion of  the spine for realignment should be 
performed first. If  the location of  pain is inconclusive 
or both are suspected to generate pain, diagnostic tests 
with intraarticular injection to the hip joint or spinal 
nerve root block if  unclear foraminal stenosis with local 
anesthetics can be motivated in order to better determine 
whether pain derives from the lumbar spine, the hip, 
or both (75, 91, 102, 105, 106). Since the evidence is 
somewhat stronger and the procedure is simpler starting 
with intraarticular injection with local anesthetics to the 
hip joint is recommended. If  the location that is most 
painful is still inconclusive, the need for spinal fusion for 
realignment or other reason needs to be determined. If  
spinal fusion is needed the recommendation is to start 
with this procedure. This since to start with the spine 
have a better outcome following THR than the opposite 
and that the risk for complications, firstly and foremost 
with dislocation of  the THR are somewhat reduced. If  
there is no need for a fixation, the type of  back pain 
needs to be considered. If  it is predominately back pain, 
starting with THR could be considered since back pain 
often reduces after THR, a relationship demonstrated 
in several studies (70, 87–90). However, those patients 
with radiating sciatic pain could more frequently be in 
the need of  a following lumbar spine surgical procedure. 
Further, THR improves the patients walking capacity 
significantly, their mobility increases and can with this 
reduce their pain from spinal stenosis and possibly 
postpone the need for a following LSSS. If  the patient 
has radiating pain in the lower limb and hip pain from 
hip OA, the recommendation is to start with spinal 
surgical procedure due to better outcome and reduction 
for risk of  complication following THR. 
Importantly, the combination of  spine and hip 
problems prior LSSS or THR surgery predispose worse 
patient-reported outcomes regardless of  surgical order, 
and these patients have a risk for future surgery in the 
other locations. This much debated issue of  where to 
start with surgery will not end with this thesis. This work 
contributes to the knowledge about the complicated 
treatment and assessment of  this group of  patients with 
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“hip-spine syndrome”, and the influence of  previous 
surgery due to degenerative diseases in the lower back 
and hip. With this thesis, new knowledge has been 
provided to the surgeon and patient in order to make 
better decisions in the shared decision-making process 
prior to surgery of  the hip or lumbar spine.
Figure 16. Algorithm presenting decision making tool to decide whether to start with total hip replacement or lumbar spine surgery 
when degenerative diseases are present in both locations.
*If  a need for future spinal fusion is suspected, this needs to be taken into consideration when positioning the acetabular cup, or the 
decision to begin with realignment of  the lumbar spine prior to THR. 
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Paper I
3.5% of  all patients in whom a THR procedure was performed in 2012 had undergone an LSS 
procedure during an 11 years period prior to their hip surgery. This estimation could however be 
considered low, since patients with LSS performed prior to 2002 were not included into the calculation. 
Patients who had undergone an LSS prior to their THR generally experienced less pain reduction, 
worse health-related quality of  life and less satisfaction one year after their THR procedure compared 
to patients with only a THR performed. There was no association of  time between surgeries with 
the outcome following THR. This knowledge is important to communicate in the shared decision-
making process prior to a THR and may help set proper expectations for the outcomes following the 
procedure.
Paper II
Patients undergoing a THR prior to their LSSS generally experience more back pain one year after LSSS 
compared with patients who had no previous history of  THR. No significant differences in health-
related quality of  life, leg pain, disability and patient satisfaction at one year were reported following the 
LSSS procedure. There was no association of  time between surgeries or type of  LSSS procedure with 
the outcome following the LSSS procedure. This knowledge is important to communicate to patients 
eligible for LSSS with a known history of  previous THR in order to set appropriate expectations for 
the outcome of  surgery. 
Paper III
In patients in whom both THR and LSSS procedures have been performed within two years, patients 
who had an LSSS first had a better outcome following their THR in the EQ-5D index and EQ-VAS 
than patients who started with THR following their LSSS. It is important to take into consideration 
that it was twice as common and that there was a significant shorter time between surgeries in those 
patients that first did LSSS. It is also important to note that this study reflects the outcomes of  routine 
care in Sweden. As such, the decision on the order of  surgery can be assumed to be the result of  a 
thorough clinical assessment and shared-decision making. The decision on where to begin should be 
individualized and balance a number of  important factors.
Paper IV
PROMs collected one year after THR are able to predict future reoperations. PROMs one year 
following THR are stronger predictors of  reoperation than age and sex. The model presented is able 
to estimate individualized reoperation probabilities at different time points. This could be used in order 
to develop a warning system to indicate those patients running a high risk of  reoperation. Including 
other baseline information in the model could increase its predictive power. 
Paper V
The derived value sets conforms well with one an-other and the EQ VAS. This could be used to create 
a standardized value set for transformations between the 3L and 5L versions in a Swedish total hip 
replacement population. The results also indicate that the EQ-5D-5L better describes HRQoL in a 
Swedish total hip replacement-population. Consequently, the new version has been adopted for routine 
follow-ups in the Swedish Hip Arthroplasty Register. 
Conclusions
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The “hip-spine syndrome”
There are several aspects that needs to be taken into 
consideration when planning for surgery in patients with 
known degenerative diseases in both the hip and lumbar 
spine, and even if  this thesis highlights some of  them, 
it is a long way from answering them all. For instance, 
no information is available today in either of  the SHAR 
or Swespine regarding patients with known degenerative 
disease but without surgery. It would be very interesting 
to investigate those patients that for various reasons do 
not proceed with surgery. For patients with hip OA, 
they might need to be identified in an early stage in the 
primary health care and then included into the registry, 
or to use the information in the BOA-registry (Better 
management of  patients with OsteoArthritis). For the 
spine patients, it would be possible to include those 
when referred to the spinal surgical department for an 
evaluation of  whether or not to perform surgery. If  
these patients could be registered, a much clearer picture 
of  this combination of  degenerative disease could be 
achieved. 
There is also the influence of  several comorbidities 
that have not been investigated in these studies 
such as smoking, BMI, prescriptions of  different 
drugs, socioeconomics and other diseases affecting 
the outcome such as pulmonary disease (chronic 
obstructive pulmonary disease), cardiovascular disease 
or psychiatric disorders. Smoking and BMI have been 
introduced in the SHAR recent years so those could in a 
future study be taken into consideration. The knowledge 
of  other comorbidities would need to be taken from the 
Swedish patient registry. Socioeconomics and prescribed 
medications could be retrieved following linkage with 
the Statistics Sweden and Swedish Precribed Drug 
Registry. 
The answer to where to start with surgery in the case 
of  degenerative hip and spine disease has not been fully 
answered in this thesis. To answer this, a RCT would 
probably be needed. As the results presents in our 
studies, there are a substantial number of  these patients 
that are in need of  surgery in both location. Following 
thorough clinical investigation, patients who presents 
with symptoms from both locations that are in the 
need of  surgical intervention, an RCT could possibly be 
Future projects
performed. To achieve enough patients would probably 
require a multicenter design. 
There is reports about the risk for complications 
following THR in patients with a previous LSS or 
patients with a LSS following the THR. Further studies 
on this subject with use of  data from the SHAR and 
the Swespine are planned. In these studies diagnoses of  
the spine leading to surgery will be considered, but also 
numbers of  segments included in the spine, fusion or 
non-fusion and involvement of  sacrum. 
The “hip-knee syndrome”
Another known combination of  degenerative disease 
that are related to the “hip-spine syndrome” is the “hip-
knee syndrome”. It is not seldom that patients with 
degenerative diseases in the hip also have degenerative 
disease in the knee. And as with the “hip-spine 
syndrome” it is in these cases sometimes difficult to 
know the origin of  pain or were to start with surgery, 
in the knee or hip. More focus regarding this dilemma 
have been presented recent years with articles produced. 
To do similar linkage studies between the Swedish Knee 
Arthroplasty register and the Swedish Hip Arthroplasty 
register as those in between the SHAR and Swespine in 
paper I to III is of  course possible and could probably 
expand the knowledge regarding this dilemma.
Detection of patients with a high risk 
of reoperation 
Following the results in Paper IV the next step would 
be to construct an automatized algorithm that scans 
the SHAR in order to detect patients with a high risk 
for reoperation. This system would then automatically 
signal the patient’s orthopedic department in order to 
present the possibility for extra follow-ups. To create 
such an algorithm, the work would be needed to expand 
beyond clinical sciences and work together with external 
collaborator with knowledge in computer science and 
possibly machine learning. 
This type of  model for detection of  complications 
following THR could possibly be expanded to 
include patients with degenerative diseases in multiple 
THE CLINICAL UTILITY OF PATIENT-REPORTED OUTCOME MEASURES IN TOTAL HIP REPLACEMENT AND LUMBAR SPINE SURGERY
56
locations such as the “spinal stenosis” or “knee OA”. 
For this purpose, there would be a need for inclusion 
of  parameters regarding both knee and spine into 
the SHAR. This could be accomplished in different 
ways. One would be to gather more background 
information in SHAR were the patient state that they 
have a condition. Or maybe the registers should be 
annually linked, exchanging information. By doing so 
those patients with a risk for complication following 
orthopedic procedures could be identified and counter 
measures made earlier. 
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Sammanfattning på svenska 
Målsättningen med det här avhandlingsarbetet är att 
undersöka den kliniska användbarheten av patient-
rapporterat utfallsmått (PROMs) hos patienter som är 
opererade med höftproteskirurgi och ländryggskirurgi. 
Avhandlingen baseras på fem delarbeten. I de tre 
första studierna undersöks utfallet efter kirurgi hos 
patienter som opererats med både höftproteskirurgi 
och ländryggskirurgi, baserat på data från Svenska 
Höftprotesregistret och Swespine (Svenska Rygg-
registret). Syftet med undersökningarna är att beskriva 
utfallet efter kirurgi i både höft och rygg samt att 
undersöka om det finns skillnader i utfall baserat på 
kirurgins ordning. I studie IV undersöks möjligheten 
att med patientrapporterade utfallsmått identifiera de 
patienter som har en ökad risk för omoperation efter 
höftproteskirurgi. I studie V undersöks om en ny 
version av det patientrapporterade utfallsmåttet EQ-5D 
har en bättre förmåga att mäta hälsorelaterad livskvalitet 
före och efter höftproteskirurgi, samt möjligheten att 
skapa en mall för att översätta den gamla versionen av 
EQ-5D till den nya. 
Både höftproteskirurgi som utförs på grund av artros 
och ländryggskirurgi som utförs på grund av spinal 
stenos är normalt framgångsrika ingrepp med förbättrad 
hälsorelaterad livskvalitet, minskad smärta och nöjda 
patienter efter respektive operation. Det finns en grupp 
av patienter som både har symptom av artros i höften 
och spinal stenos, det så kallade ”rygg-höftdilemmat”. 
Dessa patienter kan behöva genomgå ingrepp både med 
höftprotes- och ländryggskirurgi, dock är resultatet för 
den här patientgruppen relativt obeforskat. Det är också 
debatterat var det är bäst att börja med kirurgi, i höften 
eller ländryggen, hos de patienter som har besvär från 
både höften och ländryggen.
I studie I undersöktes det patientrapporterade utfallet 
efter höftproteskirurgi hos patienter som tidigare 
opererats i ländryggen, det utfallet jämfördes sedan med 
patienter som enbart opererats med höftproteskirurgi. 
De patienterna som opererats med både ländryggskirurgi 
och höftproteskirurgi hade sämre hälsorelaterad 
livskvalitet, mer smärta och mindre nöjdhet efter 
höftproteskirurgin jämfört med de patienter som 
enbart opererats med höftproteskirurgi. Dessa samband 
verifierades med hjälp av regressionsanalys.
I studie II undersöktes det omvända, det vill säga utfallet 
efter ländryggskirurgi hos patienter som tidigare hade 
opererats med höftproteskirurgi, och jämfördes med 
patienter som enbart opererats med ländryggskirurgi. 
Patienterna som opererats med först höftproteskirurgi 
och sedan ländryggskirurgi hade mer smärta i ryggen 
efter ländryggskirurgin, men det var ingen skillnad 
i övriga utfallsmått som hälsorelaterad livskvalitet, 
bensmärta eller nöjdhet med ländryggsoperationen 
jämfört med de patienter som bara opererats med 
ländryggskirurgi.
Resultaten från studie I och II talar för att patienter 
som opereras med både höftproteskirurgi och 
ländryggskirurgi riskerar att inte förbättras i den 
omfattning som patienter som bara opererats med 
antingen höftproteskirurgi eller ländryggskirurgi. 
Denna kunskap är viktig att förmedla till patienterna 
i den gemensamma diskussionen inför en eventuell 
operation för att ge korrekta förväntningar på resultatet 
av kirurgin.
I studie III undersöktes det patientrapporterade utfallet 
hos patienter som opererats med både höftproteskirurgi 
och ländryggskirurgi inom en kort tidsperiod på två år. 
Den korta tidsperioden valdes för att öka sannolikheten 
att patienterna hade besvär från både höften och ryggen 
vid tillfället för första operationen. De patienter som 
först opererats med ländryggskirurgi hade ett bättre 
utfall efter den efterföljande höftprotesoperationen 
än det omvända. Dock är det vanligare att patienterna 
börjar med ländryggskirurgi och fortsätter med 
höftproteskirurgi än omvänt vilket kan vara en signal 
om att höftproteskirurgi kan ha en skyddande effekt 
på behovet av framtida operation i ländryggen. Det går 
sannolikt inte att skapa en gyllene regel för att avgöra 
var det är bäst att börja med kirurgi. En algoritm som 
beslutsstöd har skapats för att underlätta i beslutet var 
kirurgi skall påbörjas. Det är dock viktigt att informera 
dessa patienter att de har en risk för framtida behov av 
kirurgi i både höften och ländryggen. 
Komplikationer efter höftproteskirurgi är ovanligt 
och således behöver få patienter omopereras efter en 
höftprotesoperation. Som en konsekvens av detta och 
att antalet höftprotesoperationer successivt ökar, har 
behovet för uppföljning efter samtliga höftprotes-
operationer börjat ifrågasättas. Resultatet har blivit 
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att många vårdgivare, både i Sverige men också inter-
nationellt, börjat överge rutinmässiga uppföljningar efter 
höftprotesoperationer. Det finns dock en liten andel 
patienter som behöver opereras om på grund av olika 
orsaker, till exempel infektion, att protesen lossnar eller 
att protesen går ur led. Tidigare studier som har undersökt 
vilka faktorer som kan förutsäga vilka patienter som har 
en ökad risk för omoperation har framförallt visat att 
det är patientrelaterade och kirurgiska faktorer såsom 
ålder, kön och implantattyp som har störst betydelse. 
På senare tid har det kommit några studier som visar att 
även patientrapporterade utfallsmått efter operation kan 
förutsäga risken för omoperation.
I studie IV undersöktes om patientrapporterade 
utfallsmått ett år efter höftprotesoperationen kan 
prediktera risken för framtida behov av omoperation. 
Studien visade att graden av höftsmärta och nöjdhet 
var de starkaste prediktiva faktorerna. Den modell som 
konstruerades hade en måttlig förmåga att bestämma 
risken för framtida omoperation. Det finns möjlighet 
att öka modellens prediktiva förmåga genom att tillföra 
ytterligare variabler. Med hjälp av en sådan modell är 
det möjligt att skapa en applikation som automatiskt 
avläser registerdata och identifierar patienter som löper 
en ökad risk att behöva omopereras. Dessa patienter 
skulle kunna erbjudas uppföljning och tätare kontakter 
med sin ortopedklinik. På så sätt skulle förebyggande 
åtgärder kunna sättas in tidigare, lidande för patienten 
kan minskas och samhällsresurser sparas.
Sedan Svenska Höftprotesregistret började registrera 
patientrapporterade utfallsmått 2002 har instrumentet 
EQ-5D-3L använts. Detta instrument är spritt i stora 
delar av världen och används för att mäta utfallet 
efter flera olika interventioner. Instrumentet har dock 
kritiserats för att det inte förmår beskriva lindrig 
påverkan på hälsotillståndet; stora delar av populationen 
anger att de inte har några problem i de fem dimensioner 
som frågorna avser även om deras hälsotillstånd kan 
vara påverkat. Det brukar kallas för takeffekt och märks 
tydligt bland dem som genomgått höftprotesoperation. 
Därför är de svårt att med EQ-5D-3L skilja mellan 
dem som blir helt bra och dem som har kvarvarande 
symptom eller andra hälsoproblem. Därför har ett nytt 
instrument, EQ-5D-5L tagits fram för att mer nyanserat 
kunna beskriva utfallet efter en intervention.
I studie V har ett antal patienter fått fylla i både den 
nya och gamla versionen av EQ-5D före och efter 
höftproteskirurgi. Studien visar att utfallet blir mer 
nyanserat beskrivet och takeffekterna minskar med 
den nya versionen. Det var också möjligt att skapa en 
mall för att översätta de gamla resultaten till den nya 
versionen, vilken möjliggör analyser över tid. 
Konklusioner från avhandlingen:
• Patienter som är opererade med både 
ländryggskirurgi och höftprotes har ett sämre 
patientrapporterat utfall än de patienterna som 
enbart opereras med ett ingrepp.
• De patienter som först opereras med 
ländryggskirurgi före höftproteskirurgi har 
bättre patientrapporterat utfall efter sista 
operationen jämfört med dem som opereras med 
höftproteskirurgi följt av ländryggskirurgi. 
• Med hjälp av patientrapporterade utfallsmått ett år 
efter höftproteskirurgi kan man förutsäga risken för 
framtida omoperation.
• Den nya versionen av EQ-5D med fem 
svarsalternativ för varje fråga är bättre på att 
beskriva hälsorelaterad livskvalitet hos patienter 
som genomgår höftprotesoperation än den gamla 
versionen med tre svarsalternativ. Korrelationen 
mellan självskattad hälsa mätt med en VAS-skala av 
besvär för de olika hälsodimensionerna i de två olika 
versionerna av EQ-5D följer ett logiskt mönster. 
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